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INTRODUCTION 
Siddha maruthuvam is  one of the oldest Medicine System in the world which is still 
extant, particularly in Tamilnadu. It is at least 5000 years old. Siddha system  is a 
traditional medicine system of southern India,mainly in Tamilnadu. It was founded 
and profounded by Siddhars who were yogis, philosophers, physicians, spiritual seers, 
scientists, poets. Traditionally it is taught that  Siddhars laid the foundation for this 
system of medication. Siddhars were spiritual adepts who possessed the ashta Siddhis, 
or the eight supernatural powers. Agasthiyar is considered the first Siddha and guru of 
all Siddhars. 
Siddha system of medicine  cannot be called complementary or alternative medicine 
system, as many of the medical approaches and treatment are far beyond current 
scientific standards, so it is apt to be called as Traditional or conventional medical 
system of Tamilnadu. Traditionally through Guru – Sishya priniciple, the Siddha 
medicine was learnt and passed through generations. 
Siddha  system doesn‘t consider treatment and prevention separately. The main aim of 
this system is prevention of disease, as it is well said that ―Prevention is better than 
cure‖. Siddha system emphasizes not only a healthy body but also a peaceful mind. 
Hence, it is unique when compared to other medical system. 
In Tamil, Siddhi means ―one who is accomplished‘‘. It refers to perfected masters 
who have achieved a high degree of physical as well as spiritual perfection or 
enlightment. Siddha medicines are, not  merely compounding mixtures of poly-
herbals or herbo-minerals, pills, plasters, etc, But  a multi  disciplinary system which 
comprises knowledge from various subjects like chemistry, astrology, cosmology, 
physics, psychology, spirituality, philosophies, botany, etc. For a Medicine to be 
affective, the inorganic substances have to be brought to their atomic form. Siddhars 
developed  the Knowledge of  bringing inorganic substances into atomic and ionic 
form which is easily absorbed by the system. 
According to the Siddha system, the individual is a microcosm of the universe. The 
human consists of five primordial elements-earth, water, fire, air and space, the three 
humours-vatha, pitha and kapha and seven physical constituents. Food is the basic 
building material of the human body and gets processed into humours, tissues and 
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wastes. The equilibrium of humours is considered as health and its disturbance or 
imbalance leads to diseased state.  
The concept of Siddha for diagnosis is to investigate the cause of the disease, the 
signs and symptoms, complication if any, and pathological tissue changes. The 
Siddhars look at body and disease together to arrive at a conclusion regarding the 
condition or diagnosis of the patient. This condition is an essential pre-requisite for 
treatment.  
Siddhars classified 4448 diseases in humans. Among them,the diseases of the women 
pertaining to the reproductive organs are also explained. PERUMBADU ROGAM  
which was explained by the great saint YUGIMUNI  in his text VAITHYA 
CHINTHAMANI  is one of the important gynaecological the problems that clinically 
correlate with MENORRHAGIA  in modern system of  medicine.An healthy women 
only can produce a healthy generation. Being a women,  I prefer to take PITHA 
PERUMBADU (Menorrhagia) as my dissertation which is a main gynaecological 
problem nowadays and also to give a solution through our Siddha system of medicine. 
The WHO reports  that  18  million women aged  30-55 years  perceive  their  
menstrual  bleeding  to  be  exorbitant. Reports  show  that  only  10%  of  these  
women   experience  blood  loss  severe  enough  to  cause  anaemia  or  be  clinically 
defined  as  Menorrhagia
(1)
. 
Menorrhagia  is the most common  type  of  abnormal uterine bleeding  characterized 
by heavy  &  prolonged  menstrual bleeding without any change in cycle length
(2)
. 
The symptoms of menorrhagia are well correlated with YUGI‘S PITHA 
PERUMBADU. 
Menorrhagia affects 30% of women in reproductive age
(3)
. Annually approximately 
5% of women seek medical care for excessive menstrual bleeding
(4)
. 50% of cases 
were diagnosed as DYSFUNCTIONAL UTERINE BLEEDING
(3)(4)
.
 
Totally 30% of world wide population having heavy menstrual blood loss. In India, 
about 20% of DUB cases are seen among adolescent girls and 40% of cases among 
women above 40 years of age
(5)
.
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In modern system of medicine, as the treatment is not as much effective and most 
probably hysterectomy is the solution, I had selected NAAVAL NEI a Poly herbal 
formulation from AATHMARATCHAMIRTHA VAITHIYASAARA 
SANGIRAGAM
(6)
, to give best solution for Perumbadu. 
Siddha system of medicine  has a enormous pharmacopoeia containing plants, animal 
and mineral products and treatment techniques consisting in use of 32 types of 
internal medicines and 32 types of external medicines. In that, NEI is one of the 
internal medicine. 
NEI(MEDICATED GHEE) is prepared by adding Cow ghee to certain individual leaf 
juices, decoctions of herbs or tubers and boil till the raw drugs completely mix with 
the ghee. Then it can be filtered and preserved. 
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AIM AND OBJECTIVES 
AIM:  
            The   aim   of  the  dissertation   study   is  to  analyse  the   selected   disease 
PITHA  PERUMBADU, both  clinically  and   experimentally   with   the   trial  drug  
NAAVAL NEI. 
OBJECTIVES:                                                                                                            
           To evaluate the therapeutic efficacy of  NAAVAL NEI in PITHA 
PERUMBADU (MENORRHAGIA).  
 To  collect  the  literature  of  both siddha  and modern  aspects  of  the  
disease Pitha  Perumbadu. 
 To  study   the  clinical  course  of  the disease  with  observation  on  
the  etiology, classification, pathology,  differential  diagnosis,  
prognosis,  complications  and  treatment  by  siddha  aspect. 
 To  have  an  idea  about  the  incidence of  the disease  with  age,  
occupation, economical status, habits, family  history and climate 
conditions. 
 To expose the clinical diagnostic methods mentioned by Siddhars to 
know 
how the disease manifest due to the deranged mukkutram, pori 
pulangal and ezhu udal thathukkal. 
 To have detailed clinical investigations. 
 To have the modern parameters to confirm the diagnosis and prognosis 
of the disease 
 To have a clinical trial on the disease Pitha Perumbadu with the 
siddha drug  NAAVAL NEI. 
 To  evaluate  the  drug  NAAVAL NEI    
- Bio-Chemical Analysis (Qualitative and Quantitative) 
- Toxicological Analysis (Acute  and  Sub-acute) under 
OECD Guidelines 
- Pharmacological Study (Styptic activity in Wistar 
albino rat model) 
- Statistical Analysis. 
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REVIEW OF LITERATURE 
SIDDHA ASPECT 
பெரும்ொடு 
IYAL (DEFINITION)             
          நாதயிடாய் ஒறேக்கு ன௃ணர்ச்சினி஦ால் அக்கி஦ி நீ஫ி 
வயட்டடனேண்டாகி அதிகரித்து உடம்஧ில் தாதுக்கள் ஧஬ங்குன்஫ி, கன௉ப்ட஧ 
தாதுக்கற௅ம் ஧஬ய஦ீப்஧ட்டு, கன௉க்குமினில் இபத்தம் அதிகநாகச் சசர்ந்து 
ன௃ண்ணாகி சனா஦ினின் யமினாய் இபத்தம் வசவ்யி஭஥ீர் ச஧ால் ஒறேகிக் 
வகாண்சட இன௉க்கும். இதுசய வ஧ன௉ம்஧ாடு ஋஦ப்஧டும்(7).                                                                                                                                                                                                                                                            
According to T.V.Sambasivam Pillai in his dictionary,  
Perumbadu is defined as the excessive loss of menstrual bleeding which may 
be increased in duration of menstrual bleeding or heavier blood flow without any 
change in the cycle length. 
NOI VARUM VAZHI (AETIOLOGY) 
                “கன௉திசன க஦நா஦ வகாடுடந வசய்து 
     கணயட஦சன ஥ிந்தட஦தான் வசான்஦ ச஧ன௉ம் 
              ஧ன௉தினின்ன௅ன் ந஬ச஬த்டத யிட்ட ச஧ன௉ம் 
   ஧பசதசிசன டமகட஭ப் ஧மிக்கின்ச஫ார்க்கும் 
              குன௉திசன னிடபக்கின்஫ கா஬ந் தன்஦ில் 
  கூசாநல் ன௃ன௉ரசங்டக ஧ண்ணிச஦ார்க்கும் 
              கன௉திசன ஧பசனாகம் யின௉ம்஧ி ச஦ார்க்கும் 
 சுன௉க்கிச஬ வ஧ன௉ம்஧ா டுற்஧யிக்குந் தாசந 
              தாவ஦ன்஫ காபணிகள் நிகுக்டக னாற௃ம் 
                      சண்டா஭க் சகா஧த்தின் ச஬ிப்஧ி஦ாற௃ம் 
              ஊவ஦ன்஫ நாநிசங்கள் வ஧ாசித்த ஬ாற௃ம் 
                     உ஫க்கநின்஫ி யிமித்த஬ா ற௄மித் தீனால் 
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              ஧ாவ஦ன்஫ ஧சினின்஫ிப் வ஧ாசிக்டக னாற௃ம் 
                      ஧ாபநாஞ் சுடநயாங்கல் ஧கற௃஫க்கம் 
              கூவ஦ன்஫ குறுக்க஬ாம் ன௅டக்கித் தூங்கல் 
                      குனொபநாம் வ஧ன௉ம்஧ாடு வகாட்டுந்தாச஦‖ 
-Yugi vaithiya chinthamani 800
(8)
               
                                                                                                           
 Women those who abuse or show severe cruel activity to her 
husband. 
 Women who void urine and faeces in front of sun. 
 Women who criticize sages and poor people. 
 Women who have sexual intercourse at the  time of menstruation. 
 Women who indulge in excessive sexual intercourse. 
 Women with vigorous anger. 
 Women often taking non-vegetarian foods. 
 Sleeplessness without rest. 
 Taking food without appetite. 
 Lifting heavy loads. 
 Daytime sleep. 
 Sleeping in flexed position. 
These conditions will cause the disease, Perumbadu Rogam. 
In  Mega noi, Soothaga Nool and Arivaiyar Chinthamani,   
 “கண்டாசனா வ஧ன௉ம்஧ாடு க஬ந்த நார்க்கம் 
  கன௉திக் சகள் நின்஦ாச஭ ஥ன்஫ாய் இன்னும் 
              வகாண்ட ஧டிகாபன௅ள்஭ யடககள் தின்஫ால் 
              யிண்டாற௃ம் யாய்வு அது நிஞ்சி஦ாற௃ம் 
யி஭ங்கும் நா  சம் அதிகம் ன௃சித்ததாற௃ம் 
              உண்டாற௃ம் நந்தநதில் ன௃சித்ததாற௃ம் 
                  உ஫க்கநது ஒமிந்த யிதத்தாற௃ம். 
 
              ஆகுசந கடும் சுடநவடடுப்஧தாற௃ம் 
                  கதிப்஧ாக ஧கற௃஫க்கம் ஧கல் சம்ச஧ாகம் 
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              ஧ாகு வ஧஫ குறுக்கதுதான் கூ஦ிக் வகாண்டு 
                  ஧ண்஧ாகசய உ஫ங்கும் தன்டநனாற௃ம் 
              யாகு வ஧஫சய அதிக ன௃ணர்ச்சினாற௃ம் 
                  யற௃யாக சநகநது உற்஧யித்து 
              தாகன௅஫ சூவடறேம்஧ி த஭யாய் ஥ீ஫ி 
    த஦ி யனறும் கன௉க்குமினேம் ன௃ண்ணுண்டாசந” 
                     -Mega noi, Soothaga Nool and Arivaiyar Chinthamani(9) 
                                                                                                                      
 Excessive intake of spicy foods. 
 Increase of vatha during menstrual period. 
 Increased intake of non-vegetarian foods. 
 Intake of food during indigestion. 
 Loss of sleep.  
 Taking  heavy weights. 
 Daytime sleep. 
 During daytime sexual act 
 Sleeping in flexed and improper posture. 
 Increased sexual intellectual. 
In  Agathiyar Gunavagadam, 
                      “஧ாசப ஥ீ வ஧ன௉ம்஧ாடு யன௉ம் யடகடனக் சக஭ாய் 
                  ஧க்குயநாய் யன௉கின்஫ கண்டநாட஬ 
              ஊசப ஥ீ னெத்திப குண்டிக்கானின் சபாகம் 
                  உத்தநச஦ ஧஬ீிகா சபாகந் தானும் 
              சதசப ஥ீ ஥ாட்஧ட்ட ஧ாண்டு சபாகம் 
                  வத஭ியாக இபத்தசபாகம் தன்஦ா ட஬னா 
              சீசப ஥ீ சிட஦ப்ட஧க்கும் கன௉ப்ட஧க்கு நப்஧ா 
                  சி஫ப்஧ாக அதிகபத்த சநறுங்காச஦. 
 
              காணுயாய் சூதகம் வய஭ினாகுநப்஧ா 
                  கன௉ப்ட஧தான் அமட஬வகாண்டு ச஧ாய தாச஬ 
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              ன௄ணுயாய் சம்ச஧ாக நதிகத்தா ற௃ம் 
                  வ஧ால்஬ாத ன௃த்துக஭ாற் கட்டினா ற௃ம் 
              ச஧ணுயாய் வ஧ன௉ம்஧ா டுண்டா வநன்று 
      வ஧஬நாக தீதான் வசால்ற௃யாய் உ஬கத்சதார்க்கு 
              காணுயாய் அப்ச஧ாது கன௉ப்ட஧ ஥ின்று 
                  கன௉யா஦ பத்தத்தான் யன௉குந்தாச஦” 
                                                                                             -Agathiyar Gunavagadam(10) 
Perumbadu occurs in association with the following diseases: 
 Tubercular Adenitis.  
 Renal diseases. 
 Diseases of Spleen. 
 Chronic Anaemia. 
 Pelvic Inflammatory Diseases.  
 Uterine Congestion.  
 Excessive coitus.  
 Benign and Malignant Tumours. 
 In  Aaviyalikum Amuthamurai Churukkam,                             
                       “஧ார்த்திடசய நங்டகனர்க் கிபத்த சூட஬ 
                  ஧கன௉கிச஫ ஦டியனிற்஫ில் ஧ற்஫ி ஥ிற்கும் 
              சகார்த்திடசய உதிபநது திபண்டு சநதான் 
                  வகாதிப்வ஧டுத்து நாதயிடாய்க் கா஬ந் தன்஦ில் 
              சசர்த்திடசய சூதகன௅ம் நிகுந்து காணும் 
                  சிறுயமினாய்க் கன௉யமினேம் ன௃஫ண்டு ட஭க்கும் 
              ஌ர்த்துடச஦ வதாடடனிடுப்ன௃ உட஭ச்ச ஬ாகும் 
                  இபத்தசூட஬க் குணநிதுசய ஧ான௉ ஧ாசப” 
-Aaviyalikum Amuthamurai Churukkam
(11) 
 Heavy menstrual bleeding  
 Mild abdominal pain 
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 Pain in thighs and hip region. 
 In T.V.SAMBASIVAM PILLAI
(12)
,  
  Perumbadu is an immoderate secretion of the menstrual 
discharge.  
Uterine blood vessels lose their strength, muscle fibres get 
congested leading to menorrhagia.  
In  MAGALIR MARUTHUVAM
(13)
, had listed the aetiological factors of 
Perumbadu  
 Tumours in uterus.  
 Salphingitis and Oophoritis.  
 Sepsis of Pelvic tumour.  
 Early stages of Tuberculosis.  
 Hormonal imbalance especially Hypothyroidism.  
 Endometrial Tuberculosis.  
 Peri-menopausal stage.  
 Cardiac diseases.  
 Psychological reasons.  
 Family problems.  
In ANUBHOGA VAIDHYA DEVA RAGASIYAM-shthiriroga  nithanamum, 
sigichchaiyum Part-II 
(14)
, the aetiological factors of Perumbadu are:  
 Intake of food which increases body heat.  
 Excessive intake of food.  
 Indigestion.  
 Uterine congestion.  
 Excessive coitus.  
 Climbing hills.  
 Excess walking and excess sleep.  
 Fasting.  
 Loss of body weight. 
 Lifting heavy weights 
 Injury by sticks and rods 
 Daytime sleep. 
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சூதகம் உண்டாகும் விதம்  
               “திங்கற௅று நங்டகனர்கள் வகற்஧ாசனநடத      
                  தாங்கினின௉ சியிடகனேண்டு 
              சியிடகனின௉ ஧க்கன௅ம் யசீிசன 
                  ஥ிற்குநதி஦ின்வ஫ான௉ குமல் ஥பம்ன௃ 
              ஧ங்கந஫சயவனறேம் அடியனிறு சனா஦ினேம் 
                  சுற்஫ிப் ஧ிடணந்து வகாண்டு 
              ஧கன௉நதிவ஬ான௉ ன௅ட஦ இபத்தாசனநடதக் 
                  கவ்யிக் குயிந்தின௉க்கும் 
 
              இங்கிதநதாகசய நறுன௅ட஦னது 
                  அரிடயனர் வகற்஧ாசனம் ன௃குந்து  
              இ஦ிதானபயினுட யான஭யாகசய 
                  னெயிப஬டசந்து ஥ிற்கும் 
              நங்க஭நதானிந்த ஥ாதக்குமல் 
                  யமி பத்தாசனத்தி஦ின்று 
              நறுயக஬சய காரிபத்தம் சுபந்தி஦ி  
                  வகற்஧ாசனததிச஬ தான் 
 
              ஥ிதன௅நிது தய஫ாது ஒசப து஭ியிறேம் 
                  ஆ஫ஞ்சதாம் ஥ா஭ிச஬ 
              ச஥சவநான௉ குமல்யமி உன௉கினது வய஭ினிச஬ 
                  ஧ானேநது சனா஦ி யமினாய் 
              ஧தநாகசய சுகசதகினதுயாகிவ஬ா 
                  ன௄த்த ன௅தல் னென்று ஥ாற௅ம் 
              ஧கன௉தி஦ி சநாபாற் கமஞ்சு ஥ிட஫ ஧ானேசந 
                  சநகநதி஦ால் சூட்டி஦ால் 
              இதநா஦ யானேயால் கின௉நினின் ஌துயால் 
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                  ன௄த்த ஧ின் கணயச஦ாசட 
              சசன௉யதி஦ாச஬னேம் கடு஥டடக஭ா஬ி஦ி 
                  சுநடு வயனில் தாக்குயதி஦ால்  
              யிதநா஦ ஥ாதநது கூடும் குட஫ந்திடும் 
                  வகற்஧நில்஬ாந஬ாகும் 
              யிள்ற௅சநாபாறு யடக யானேயது 
                  துதித்திடும் சகற௅ ஥ீ ஒவ்வயான்஫ாய் 
-Arivaiyar chinthamani
(15) 
                                                                                               
PERUMBADU – CLINICAL FEATURES     
                        
In  Mega noi, Soothaga Nool and Arivaiyar Chinthamani,  
                                                                                
             “டகனேடன் காற௃ங் காந்துங் காத்திப ன௅஬ர்ந்து யற்று 
  டநன஬ாங் க஬யி தன்ட஦ நறுத்திடுங் கர்ப்஧ங் சகடாஞ் 
            வசய்ன஥ீர் ச஧ாற௃ஞ் சற்ச஫ சியந்திடும் குன௉திச஧ாற௃ம் 
               வ஧ய்னேசந னாகில் நாச஦! வ஧ன௉ம்஧ாவடன்஫஫ிகுயசீப” 
-Mega noi, Soothaga Nool and Arivaiyar Chinthamani(16) 
       
 Burning sensation of upper and lower limbs                                                                                                                                   
 Emaciation of body 
 Loss of libido 
 Failure to conceive  
 Watery or reddish vaginal discharge      
In  Agathiyar Gunavagadam 2000-2nd Part,   
                                                                  
“இபத்த வநான௉க்கால் தடகனாநல் வ஬஦சய சனாடுச஧ால்  யறீேந் 
     தின௉க்கும் சிபத்தில் க஦ப்ன௃ன௅ண்டாகும் திதநாய் சிதகிச஫ யிமபத்தம் 
           சாத்த பத்த சபாகவந஦ச் வசால்ற௃ம் ஥ல்஬ யல்஬சப” 
                    -Agathiyar Gunavagadam 2000(17)                                                              
 Excessive bleeding with clots 
 Head ache 
 Scattered blood 
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 In  Mega noi, Soothaga Nool and Arivaiyar Chinthamani,   
                                   
               “வய஭ியாக இபத்த சூட஬ வசால்஬க் சகற௅ 
                 யிடபயாக அடியனிற்஫ில் இபத்தம் வகட்டி 
              வத஭ியாக ன௄க்குநந்த கா஬ம் தன்஦ில்  
                  திட்டநாய் இபத்தநது அதிகம் ஧ானேம் 
              க஭ியாக யன஫த஦ில் ச஥ாவுண்டாகும் 
                  கன௉யமிக்கும் யனறு஧ிபட்டும் க஦ ச஥ாயாகும் 
              அ஭ியாக இடுப்ன௃ துடட அனர்ந்து ச஧ாகும் 
                  அ஫ிகுயாய் இபத்த சூட஬வனன்று வசப்ச஧”  
 
                                 - Mega noi, Soothaga Nool and Arivaiyar Chinthamani (18)                                                                                                                                                                                                                                                                                                                                  
                    
 Excessive menstruation 
 Lower abdominal pain 
 Pain in thighs and hip region. 
NOI ENN (CLASSIFICATION) 
In Yugi vaithiya chinthamani,  
              “உடப வசய்த வ஧ன௉ம்஧ாடு ஥ா஬ தாகும் 
                  உகந்துசந யாதத்தின் சிபாய வநான்று 
             ன௃டப வசய்த ஧ித்தத்தின் சிபாய வநான்று 
                  ச஧பா஦ சசட்டுநத்தின் சிபாய வநான்று 
             துடப வசய்த வதாந்தநாஞ் சிபாய வநான்று 
துடகவனல்஬ாம் ஥ாயிதச் சிபாய நாச்சு” 
                                                               -Yugi vaithiya chinthamani(19)                                                 
 
Perumbadu is of 4 types name types 
 VATHA PERUMBADU 
 PITHA PERUMBADU 
 KABHA PERUMBADU 
 THRITHOSA PERUMBADU. 
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CLASSIFICATION  OF PERUMBADU 
In  Yugi Vaithiya Chinthamani,  
 PITHA PERUMBADU 
 
               “ஆவநன்஫ யன்஦த்டத இ஫ங்வகாட் டாது 
                  அறேகின்஫ நஞ்சள் ஥ி஫ம் ச஧ா஬ ஊற்றும் 
              சயவநன்஫ சனா஦ினிச஬ சயக்கா டுண்டாம் 
                  சந஦ினேசநா வயற௅த்துசந பத்தம் ச஧ாகும் 
              காவநன்஫ கால்டகனே நமற்஫ ஬ாகும் 
                  கன௉க஬ாய்க் கட்டிச஧ா ற௃திபம் யறீேம் 
              சதவநன்஫ சிறுகடுப்஧ா நங்க வநல்஬ாம் 
                  சீரின சதார் ஧ித்தத்தின் சிபாய நாசந” 
       -Yugi Vaithiya Chinthamani(20) 
 Loss of  appetite 
 Menstrual bleeding with slight yellowish color tinch. 
 Soreness of vagina 
 Pale color of the body. 
 General weakness of Limbs 
 Menstrual bleeding with Black coloured blood clots 
 Pain in the body 
 
In  Mega noi, Soothaga Nool and Arivaiyar Chinthamani, 
                                                                                                                                                                                                                                                           
PITHA PERUMBADU 
 
                “வசால்ற௃சயன் ஧ித்தத்தின் வ஧ன௉ம்஧ாவடன்஫ால் 
                  சுடும் நஞ்சள் ஥ி஫ம் வபத்தம் வயறுக்கும் அன்஦ம் 
              சல்஬ினநாய் சனா஦ினது வயந்து ஥ீறும் 
                  சாயாக உடல் வயற௅க்கும் பத்தம் யற்றும் 
              வநல்஬சய கால் டகனேம் காந்தற௃ண்டாம் 
                  வநய்னேன௉கி கட்டினதாய் இபத்தம் ச஧ாகும் 
              இல்ட஬னி஦ி சதகநது உட஭னேம் சற்று 
                  இது ஧ித்த வ஧ன௉ம்஧ாவடன்று உடபக்க஬ாசந” 
                                -Mega noi, Soothaga Nool and Arivaiyar Chinthamani(21)                                                             
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 Pale coloured menstrual bleeding with yellowish tinch.  
 
 
 Aversion on food 
 
 Burning sensation on vagina 
 
 Pale color of the skin due to decreased haemoglobin 
 
 Burning sensation on palms  and soles 
 
 Menstrual bleeding with clots 
 
 Pain all over the body. 
 
CLASSIFICATION OF  OTHER  PERUMBADU  TYPES 
 
In  Yugi Vaithiya Chinthamani,   
 
VATHA PERUMBADU 
             “கூடுசந தட஬ய஬ினே சநற்க டுப்ன௃ம் 
                  கூ஫ா஦ ன௅துகிடுப்ன௃க். குடடச்ச ற௃ண்டாம் 
             யாடுசந சதகவந஬ாங் கன௉க்க ஬ாகும் 
                  நாதயிடாய் கரித்துசந டநந்தன் ச஧ா஬ாம் 
             ஊடுசந யனிறூதி உட஭ச்ச ஬ாகி 
                  ஊற்றுசந வசந் ஥ி஫ன௅ங் கன௉க ஬ாகத் 
             சதடுசந துற்கந்தஞ் சசப வயாட்டா  
                  வசகந஫ின யாதத்தின் சிபாய நாசந” 
-Yugi Vaithiya Chinthamani
(22) 
 Head ache 
 Pain in back and hip region 
 Abdominal distension 
 Body pain 
 Dark coloured menstruation bleeding. 
 Menstrual bleeding with foul smell. 
KABHA  PERUMBADU 
 
                                 “ஆகுசந வயள்ட஭ ஥ி஫நாக ஊற்றும் 
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                  அ஬ினா஦ ஥ாற்஫ந்தான்  நிகவுண் டாகும் 
              சயகுசந வுடம்வ஧ங்கும் யின௄தி ன௄க்கும் 
                  வயந்தம஬ா னேடம்வ஧ங்கும் ஋ரிச்ச ஬ாகும் 
              ஧ாகுசந ஧ட஧டப்ன௃ னெச்சு ன௅ண்டாகும் 
                  ஧ாபநாங் சகாடமவனாடு நனக்க நாகும்           
              சதகுசந னடிக்கடிக்கு நனக்க நாகும் 
                  சசட்டுநத்தின் சிபாய வநன்ச஫ வசப்஧ாசந” 
-Yugi Vaithiya Chinthamani
(23) 
 
 Pale  coloured menstrual bleeding 
 Foul smell menstruation bleeding. 
 Salty appearance on the body. 
 Burning sensation on all over the body  
 Palpitation 
 Cough with fatigue. 
THRITHOSHA PERUMBADU 
 
            “வசப்஧சய கன௉கல்஬ாய்ச் சியப்ன௃ நாகும் 
                  சசர்ந்ததிச஬ கட்டினாய்க் கன௉ப்஧ாய் யறீேம் 
              உப்஧சய யனி஫து ன௅ல்ட஬ச்ச ஬ாகும் 
                 ஊச஬ா ஥ாற்஫ன௅ட வ஦ாறேக்க நாகும் 
              ஥ம்஧சய நஞ்சள் ஥ி஫ ஥னப்ன௃ நாகும் 
                           ஥ாணிசன தட஬தானு ஥டுக்க ஬ாகும் 
              துப்஧சய யாய் ஥ீன௉ நிகசய வூற்றும் 
                     வதாந்தநாம் வ஧ன௉ம்஧ாடு சூட்டிச஦ாசந” 
-Yugi Vaithiya Chinthamani
(24)                                                                
                                                                                                                
 
 
 Dark brown  coloured menstrual bleeding with clots. 
 Abdominal distension with pain. 
 Menstrual bleeding with foul smell. 
 Tremors of the head. 
 Increased salivation. 
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In  Mega noi, Soothaga Nool and Arivaiyar Chinthamani, 
                                                                                                                                                                                                                                                                                                                                              
VATHA PERUMBADU 
 
              “஧ாடாநல் யாதத்தின் வ஧ன௉ம்஧ாடுற்஫ால் 
                  ஧ண்஧ாக தட஬ய஬ிக்கும் சதகம் ச஥ாகும் 
              ஥ாடாநல் ன௅துவகாடு இடுப்ன௃ தானும் 
                  வ஥ாந்து நிக யன௉த்தநிகும் உட஭வுண்டாகும் 
              கூடாகவுடல் வந஬ினேம் கன௉கும் சதகம் 
                  வகாள்ற௅ம் நாதயிடாய் கா஬ம் யனறு ச஥ாகும் 
              ஊடாகசய உன௉ற௅ம் குமந்டத ச஧ாச஬ 
                  உறு வ஧ன௉நல் வசந்஥ி஫நாய் இபத்தம் ஥ாறும்” 
-Mega noi, Soothaga Nool and Arivaiyar Chinthamani(25) 
 Head ache 
 Pain all over the body 
 Pain in the back and hip region. 
 Loss of  weight 
 Lower abdomen pain during menstruation 
 Dark red coloured  menstrual bleeding with foul smell. 
KABHA PERUMBADU  
 
               “ச஧ாசந சசர்ப்஧஦த்தின் வ஧ன௉ம்஧ாவடன்஫ால் 
                  வ஧ான௉ந்து வயள்ட஭ ஥ி஫நாக பத்தம் யிறேம் 
              யாகுவ஧஫சய ஥ாறும் சதகம் தானும் 
                  ய஭ர் ஥ீறும் ச஧ாவ஬ரினேம் அமற௃ம் சதகம் 
              தாகன௅றும் ஧ட஧டத்து னெச்சு யாங்கும் 
                  த஦ித்த க஧நின௉நவ஬ாடு சயவுண்டாகும் 
              ஧ாகுவ஧஫ அடிக்கடி நனக்கன௅ண்டாகும் 
                  ஧கன௉சயன் சசர்ப்஧஦த்தின் வ஧ன௉ம் ஧ாவடன்ச஫” 
 
-Mega noi, Soothaga Nool and Arivaiyar Chinthamani(26) 
 Pale coloured menstrual bleeding 
 Menstruation with foul smell 
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 Buring sensation on whole body 
 Increased thirst 
 Palpitation 
 Dyspnoea 
 Cough 
 Fatigue. 
THRITHOSHA PERUMBADU 
 
              “உண்டா஦ திரிசதார வ஧ன௉ம்஧ாவடன்஫ால் 
                  உள்஭஧டி கல்ற௃ப் ச஧ால் கட்டினாகும்  
              யிண்டு கறுப்ப்஧ாய் சிகப்஧ாய் நஞ்சள் ச஧ாற௃ம் 
                  யிதம் யிதநாய் இபத்தநது ஥ி஫ம் நா஫ிப் ச஧ாம் 
              கண்டாற௃ம் யனறுட஭னேம் ஥ாற்஫ம் நீறும் 
                  கடிதா஦ தட஬ ஥டுக்கம் யாய் ஥ீனொறும் 
              நிண்டாத திரிசதார வ஧ன௉ம்஧ாடின் 
                  நிகு வ஧ன௉டநனேள்஭஧டி வசப்஧ிச஦ச஦” 
 
-Mega noi, Soothaga Nool and Arivaiyar Chinthamani(27) 
                                                                                                                                                                                                                                                                         
 Black , red or yellow coloured menstrual bleeding. 
 Abdominal distension. 
 Foul smell bleeding 
 Tremors of the head. 
 Increased salivation. 
சாத்தியம் மற்றும் அசாத்தியம்  
 
In  Yugi Vaithiya Chinthamani,
 
 
              “சூடினசதா பசாத்தினத்டதச் வசால்஬க் சக஭ாய் 
    வசால்ற௃ம்சசட்஧ வ஧ன௉ம்஧ாடு வதாந்தசசி பாயம் 
              ன௄ட்டி஦சதா ரிபண்டும் ஧ிடமக் வகாட் டாது 
                  ன௃கமா஦ சாத்தினத்டத யி஭ம்஧க் சக஭ாய் 
              யாட்டி஦சதார் யாதத்தின் வ஧ன௉ம்஧ா சடாடு 
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                  யடகனா஦ ஧ித்தத்தின் சிபாயந்த் தானும் 
              தீட்டி஦சதார் நன௉ந்துக்குச் வசனன௅ நாகும் 
  வசப்஧ி஦சதார் ஥ன்னூட஬த் வத஭ிந்து ஧ாசப” 
                                                         -Yugi Vaithiya Chinthamani
(28)
           
 
 Vatha perumbadu and pitha perumbadu were curable. 
 Kabha perumbadu and thrithosha perumbadu were non-curable. 
 
In Mega noi, Soothaga Nool and Arivaiyar Chinthamani, 
                                                                                                                                                                                                                                                                                                                    
               “சாற்றுசயன் யாதத்தின் வ஧ன௉ம்஧ாவடான்று 
                  ச஬ினாநல் ஧ித்த வ஧ன௉ம்஧ாடு தானும் 
              ச஧ாற்஫ினசதார் சசர்ப்஧ வ஧ன௉ம்஧ாவடான்று 
வ஧ான௉ந்து திரிசதார வ஧ன௉ம்஧ாடு ஥ா஬ாம் 
              ஆற்஫ினசதார் யாத வ஧ன௉ம் ஧ாடிச஦ாடு 
                  அதிகநாய் ஧ித்த வ஧ன௉ம்஧ாடு தீன௉ம் 
              நாற்஫ினசதார் சசர்ப்஧ வ஧ன௉ம் ஧ாடிச஦ாடு 
நன௉வு திரிசதார வ஧ன௉ம்஧ாடு அசாத்தினம்” 
 
-Mega noi, Soothaga Nool and Arivaiyar Chinthamani(29) 
                                                                                                               
  
                                                                                                                                                           
 Vatha perumbadu and pitha perumbadu were curable. 
 Kabha perumbadu and thrithosha perumbadu were non-curable.  
பெரும்ொட்டிலுண்டாம் ததாடக்குறி குணங்கள்       
 
           “டசசனாக வயம்டந சார்ந்துசந வயட்டடனாகும் 
           வநய்னாக யிந்து யழீ்ந்திடம் வயந்து ன௃ண்ணாம் 
           டநனைன௉ம் கண்ணாட் காம்வ஧ன௉ம் ஧ாடுதானும் 
           வகாய்னைன௉ங் குய்னங் வகாப்஧஭ிங் குங்குன௉தி.” 
                                                                                          
                   “சதகத்தூறு ந஦ற௃ம் தீதாநதி வ஬ரிச்சல் 
           சயகப்வ஧ன௉ம்஧ாடு வயண்ணி஫நாய்ப்—ச஧ாகயதில் 
           ஥ாற்஫சநல் னெச்சு ஥யி஬க்க஧ நனக்கம் 
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சதாற்஫வுடல் சானேஞ் வசால்”    
        -   Noi  Naadal noi Mudal Nadal Part - I 
(30)
   
                                                 
 
 Burning sensation on all over the body 
 Pale coloured menstrual bleeding 
 Foul smell menstruation 
 Dyspnoea 
 Cough 
 Fatigue 
MUKKUTTRA VERUPAADUGAL (PATHOLOGY) 
According to Siddha system, Body is constituted by 96 thathuvaas. Normal 
structural and physiological state of the body is maintained by equilibrium with 
Mukkuttram and Seven Udarkattukal.  
As the udarkattukal are affected by the extrinsic and intrinsic factors, there is 
deterioriation in the structural and functional status of the body. When the causative 
factor affects Udarkattukal and Mukkuttram, it results in incoordination of functions. 
Thereby the disease manifest and expose its clinical features.  
In Perumbadu, the clinical condition is due to the imbalance of PITHAM. 
Pitham is deranged primarily and later it deranges vatha and the derangement of 
Pitha-vatha leads to the derangement of Abanaan which in turn cause the disease. The 
pathogenesis of the disease depends upon the affected Pitha and Vatha. 
DIAGNOSIS OF PERUMBADU BASED ON SIDDHA SYSTEM : 
  According to Siddha System the diagnosis of a disease is reached by the method   
ENVAGAI THERVU OR PINIARIMURAIMAI. 
The disease Perumbadu Rogam was diagnosed by the following methods: 
 Poriayaal arithal 
 Pulanaal arithal 
 Vinaathal 
 Uyir thathukkal 
 Udal thathukkal 
 Envagai thaervu. 
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PORIYAAL ARITHAL – Porigal-5 organs of perception 
 Nose 
 Tongue 
 Eye 
 Skin 
 Ear 
PULANAAL ARITHAL – functional units of porigal 
 Odour (smell) 
 Taste 
 Vision 
 Touch (tactile) 
 Sound (hearing) 
VINAATHAL  
                        Patient name, age, occupation, native place, socio-economic status, 
family history, diet habits prone for any allergens, period of suffering, history of 
previous episode,  history of treatment, habits etc are  noted  through  interrogation.                                                                                                                
                                                                                                                                          
UYIRTHATHUKKAL 
                         Panchaboothams are manifested in the body as three vital forces. 
 Vaatham 
 Pittham 
 Kabham 
VAATHAM  
 It is the combination of vayu and aakasha boothams. It is responsible for all  
the movements of the body. It helps in the uniform functioning of 7 Udalthathukkal. 
The sites of vaatham: 
 Umbilicus, rectum, faecal matters, abdomen, anus, bones, hip joint, naval, 
plexus, joints, hair follicles and muscles.  
Vaatham has ten types : 
1. Praanan (Uyirkaal) :  
This controls knowledge, mind and five sense organs, which are useful for 
breathing and digestion. 
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2. Abaanan (Keezh nokku kaal) :  
This is responsible for all downward movements such as passing urine, stools, 
semen, menstrual flow etc. 
3. Samaanan (Nadukkaal) :  
This aids in proper digestion. 
4. Viyaanan (Paravukaal).   
This is responsible for all movements of all parts of the body. 
5. Uthaanan (Mael Nokkukaal)  
Responsible of all upward visceral movements, such as vomiting, nausea and 
cough. 
6. Naagan : 
Responsible for opening and closing the eyes. 
7. Koorman :  
Responsible for vision and yawning. 
8. Kirukaran : 
Responsible for salivation, nasal secretion and appetite. 
9. Devathatthan :  
Resposible for Laziness, sleeping and anger. 
10. Thananjeyan :  
Produces bloating of the body after death.  It escapes on the third day after death 
bursting out of the cranium. 
In Perumbadu Rogam 
Pranan  -  Affected because of breathlessness and dyspnoea due to low 
Hb. 
Abanan - Affected because of excessive and prolonged menstrual  
bleeding. 
Samaanan - Affected because of loss of appetite. 
Viyaanan - Affected because of lower abdominal pain, low back ache and     
body pain 
Uthanan  -  Not affected 
Naagan   -  Not affected 
Koorman   -  Not affected. 
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Kirukaran -  Not affected 
Devathattan -  Not affected 
Thananjeyan -  Not affected  
PITTHAM   
 It is the life manifestations of ‗THEE‘ bootham in the body.  It is the 
metabolic thermal life force of the body.  It carries out digestion, absorption, 
metabolism, colouring of blood etc. 
The  sites of Pittham: 
  Praana vaayu, urinary bladder, moolaakkini, heart, umbilical     
 region, abdomen, stomach, sweat, saliva, blood, eyes and skin. 
Pitham has 5 types  
 
           1. Analagam     : It promotes appetite and helps in digestion. 
2. Ranjagam     : It gives colour to the blood. 
3. Praasagam    : It gives complexion to the skin. 
          4. Aalosagam     : It brightens the eyes. 
5. Saadhagam   : It controls the whole body.  It has the property to fulfill 
                           all the activities which the mind desires. 
In Perumbadu Rogam 
Analagam              -  Affected because of loss of appetite. 
Ranjaga Pitham   -   Affected because of low Hb level 
Saadhaga Pitham -   Affected because the person is unable to do her regular work      
   properly  
Alosaga Pitham -     Not affected 
Prasaaga Pitham -   Affected because of the pale and dry skin. 
KABHAM  
         It has Neer and Mann boothams. It is responsible for co-ordination and 
defence mechanisms of the body. 
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The sites of Kabham : 
                    Samaana vaayu, semen, suzhumunai, blood, phlegm, bone marrow, nose, 
chest, nerve, bone, brain, eyes and joints. 
Kabham has 5 types 
 1. Avalambagam     : Lies in the lungs, controls the heart and other kabhams. 
 2. Kilethagam          : Lies in the stomach, makes the food moist, soft and helps in  
                                  digestion. 
 3.Pothagam             : Responsible for identifying taste. 
4.Tharpagam           : Present in the head and responsible for the coolness of both 
eyes. 
5. Santhigam            : Responsible for lubrication and free movements of joints.  It is   
                                  situated in the joints. 
 In Perumbadu Rogam 
Avalambagam  - Affected because of low Hb level. 
Kilethagam       - Affected because of loss of appetite. 
Pothagam         -   Not affected 
Tharpagam      -   Not affected 
Santhigam     -    Affected because of pain in joints. 
EZHU UDAL THATHUKKAL  
 Normal functions  
Saaram   
 It gives the good spirit to body and mind. 
Senneer 
 Blood imparts colour to the body and nourishes the muscle responsible for the  
            ability, intellect of the individual. 
Oon  
 It gives shape to the body according to the requirements for the physical 
activity,  
            nourishes bone. 
Kozhuppu  
 It helps in lubrication of different  organs. 
Enbu  
 Supports  and  responsible for  posture  and  movements of  the body. 
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Moolai  
 It fills the bony cavity and gives nourishment. 
Suronitham  
 It is responsible for the reproduction. 
 
In Perumbadu Rogam 
Saaram      :  Affected due to loss of appetite and Tiredness.  
Senneer      :  Affected due to pallor of the skin and low Hb levels. 
Oon             :  Not Affected 
Kozhuppu   : Not Affected 
Enbu          : Not Affected 
Moolai         : Not Affected 
Suronitham : Affected due to excessive or prolonged menstruation. 
 
ENVAGAI  THERVU 
          “வநய்க்கு஫ி  ஥ி஫ந்வதா஦ி  யிமி஥ாயின௉ந஬ம்  டகக்கு஫ி” 
-Noi Naadal Noi Mudal Nadal Part – I(31) 
 
 Envagai thervugal can be done by the following,                                                                                                                                                                                                                                                           
Naa 
Niram 
Mozhi 
Vizhi  
Malam 
Moothiram 
Naadi 
Sparisam 
NAA (Tongue) 
Colour 
Coated 
Taste 
Dryness 
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Ulceration 
            In Perumbadu Rogam ,tongue is not affected but non-specific and unrelated 
symptoms such as dryness ,coating and ulceration may be seen in some cases. 
 
NIRAM (Colour) 
Skin Colour 
 In Perumbadu Rogam,Paleness of skin was noted in most of the cases. 
 
MOZHI (Voice) 
Articulation or speech 
 In Perumbadu Rogam,low pitched voice was seen due to severe pain in lower 
abdomen. 
VIZHI (Eyes)  
Niram  (Pallor, icterus) 
 In Perumbadu Rogam,pallor was seen in most of the cases but no other 
abnormality was seen. 
MALAM (Motion) 
Niram            -   Colour 
Irugal, Ilagal -  Consistency 
Manam          -  Odour 
 In Perumbadu Rogam,constipation may be seen in some cases. 
 
MOOTHIRAM (Urine) 
                     The urine of the patient was collected are tested for Neerkuri and 
Neikuri. 
 
Collection of urine for testing: 
                                  “அன௉ந்துநா஫ிபதன௅ம் அயிசபாதநதாய் 
                     அஃகல் அ஬ர்தல் அகா஬வூன் தயிர்ந்தமற் 
                குற்஫஭யன௉ந்தி உ஫ங்கி டயகட஫ 
                     ஆடிக்க஬சத் தாயிசன காது வ஧ய் 
                வதான௉ன௅கூர்த்தக் கட஬க்குட்஧டு ஥ீரின் 
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஥ி஫க்கு஫ி வ஥ய்க்கு஫ி ஥ின௉நித்தல் கடச஦ ” 
-Noi Naadal Noi Mudal Nadal Part – I(32) 
This stanza explains the rules for the collection of urine for Nirakuri and 
Neikuri. 
NEERKURI 
             The collected urine should be noted for the following 5 characters, 
Niram             -           Colour 
Edai             - Specific gravity 
Nurai   - Frothy 
Manam             - Odour 
Enjal  - Deposit 
                In Perumbadu the urine is clear without froth. 
 
NEIKURI 
                              “ ஥ி஫க்கு஫ிக் குடபத்த ஥ின௉நாண ஥ீரிற் 
                                 சி஫க்க வயண்வணய்சனார் சிறுது஭ி ஥டுயிடுத் 
                                 வதன்று஫த் தி஫ந்வதா஬ி ஌காதடநத்ததி 
                                  ஥ின்஫தியட஬ ச஧ாம் வ஥஫ியிமின஫ிவும் 
                                  வசன்஫து ன௃கற௃ஞ் வசய்திடன னேணசப ” 
-Noi Naadal Noi Mudal Nadal Part – I(33) 
This stanza describes the speciality of Neikuri.Of all diagnostic methods Neikuri 
reveals the true nature of the disease. 
                                       Snake like appearance  - Vatham 
                               Ring like appearance     - Pitham 
                               Pearl like appearance     - Kabham 
 
      In Perumbadu when a drop of oil is put in the patient‘s freshly collected 
urine the oil drop spreads like a snake which indicates Vatha neer. 
NAADI(PULSE) 
              ஥ாடி னென்ட஫னேம் ஥ாடிடுங் காட஬ 
              ஥டுயிபல் ஥ாடிடன ஥ாடிசன கணிப்஧ான் 
              ஥ற்஫யர்க்குன௉வய஦ ஥யிற௃ நட஫சன 
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-Noi Naadal Noi Mudal Nadal Part – I(34) 
                                                                                                                                                                               
ABNORMAL NAADI INDICATING PERUMBADU ROGAM 
 
In perumbadu  Rogam, Pitha naadi and vathathil ushna naadi was diagnosed 
 
 
               “உறுதினேள்஭ ஧ித்தநது சதான்஫ில் வயப்ன௃  
                  உஷ்ணயானே யத்திசுப நதிசா பங்கள் 
              ந஫தினேடன் கிறுகிறுப்ன௃ ஧னித்தின சபாகம் 
                  ய஭ர்சசாடக னமவ஬ரிவு காந்தல் டகப்ன௃ 
              இன௉தனத்தில் க஬க்கநது ந஫ப்ன௃ தாகம் 
                  ஋றேங்க஦வு சநனட஦வு நனக்க னெர்ச்டச 
              சி஫ிதுவ஧ன௉ம் ஧ாடுபத்தம் ஧ிபசந கங்கள் 
                  சசர்ந்துநிகு ஧ிணி஧஬வுஞ் சி஫க்குந் தாச஦ ” 
-Noi Naadal Noi Mudal Nadal Part – I(35) 
                                                                                                                                                                                               
 
       “சி஫ப்஧ா஦ யாதத்தி ற௃ட்டிணந் தாச஦  
                  சசர்ந்திடுகி ஬திசாப ன௅ட஭ச்சல் யானே 
              உடபப்஧ா஦ வ஧ான௉நவ஬ாடு அக்கி஦ி நந்தம் 
                  உள்஭ாகும் ஥ீர்ச்சிறுப்ன௃ ஧ிபசந கங்கள் 
              ஧ி஫ப்஧ாடு நதகரி஥ீர் கபப்஧ான் பத்தம் 
                  ஧ிபசநகம் வ஧ன௉ம்஧ாடு ன௃஫஥ீர்க் சகாடய 
              அ஫ப்஧ா஦ யானேசூட஬ சசத்துந சபாகம் 
                  ஆ஦஧஬ ஧ிணிகற௅சந யந்தடன௉ந் தாச஦ ”(36) 
-Noi Naadal Noi Mudal Nadal Part – I(36) 
     
LINE OF TREATMENT 
                   It is mentioned in the siddha system that treatment of disease should be in 
the basis of, 
 KAAPU 
 NEEKAM 
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 NIRAIVU 
KAAPU 
           It is the method of preventing the disease.Prevention is better than cure. 
Sarabenthirar rules to be followed at the time of menstruation: 
 Purgatives should be avoided 
 Make-ups especially corryllium should be avoided 
 Oil bath should be avoided 
 Jumping,too much of crying, laughing and heavy works should be 
avoided. 
 Sexual intercourse at the time of menstruation should be avoided. 
NEEKAM 
           It is the method of eliminating the disease etiology. 
 
 For purgation: 
                        Agasthiyar kuzhambu - 100mg with chukkukasayam should be 
administered as single dose at early morning  before commencement of treatment. 
Administration of trial drugs: 
Naaval nei - 5 ml; thrice a day for one mandalam(48 days) after food during 
menstruation. 
Pathiya pathartham: 
  Proper dietic regimen enhances the effect, bioavailability of the medicine and 
helps to maintain good health. This form of medical advice in Siddha is termed as 
Pathiyam. If Pathiyam is not followed properly, certain foods may become 
incompatible and antagonise the effect of medicine and produce harmful effects to the 
body.                
Abathiya pathartham 
      
                     “வகாள்ற௅ காடி குநட்டிக்காய் ஧ன்஫ி வகாக்குடச஦ 
          ன௅ள்஭ிற் வ஧ரின ஧ாகற்காய் ன௅தின௉ம் அயடப ஧னற்஫ங்கால் 
஧ள்஭த் வதற௅ந்த நடற்சசம்ன௃ ஧டன௉ம் யள்஭ி ஧ா஬னிடய 
           ஋ள்஭த் தட஦தான் தின்஧சீபல்  ஋ல்஬ா நன௉ந்தும் இமந்தீசப” 
-Pathartha Guna Chinthamani
(37)
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வகாள்ற௅, காடி, குநட்டிக்காய், ஧ன்஫ி இட஫ச்சி, வகாக்கு, ஧ாகற்காய், 
அயடபகாய், உற௅ந்து, சசம்ன௃, ஋ள்ற௅ ன௅த஬ினயற்ட஫ தயிர்க்க சயண்டும். 
Itchaa pathiyam   
 “கடுகு ஥ற்஫ி஬த் வதண்வணய் கூழ்஧ாண்டங்கள் கடட஬ 
               யடுய தாகின வதங்குநா யன௉க்டக ஥ற்கானம் 
          நடியி ஬ாதவயள் ற௅ள்஭ி வகாள்ன௃டகனிட஬ நதுவ஧ண் 
             இடறு ஧ாகச஬ா டகத்தி ஥ீக்கிட஬ிச் சா஧த்தினம்” 
-Pathartha Guna Chinthamani
(38)
                                                                                                                                                                      
 
கடுகு, ஥ல்வ஬ண்வணய், கடட஬, கூழ்஧ாண்டங்கள், சதங்காய், நா, 
஧஬ா, வ஧ன௉ங்கானம், ன௄ண்டு, வகாள்றெ, ன௃டகனிட஬, நது, வ஧ண்ச஧ாகம், 
஧ாகல், அகத்தி ன௅த஬ினயற்ட஫ தயிர்க்க சயண்டும். 
YOGASANA 
                Yoga helps us directly to hold physical forces in balance indirectly to 
develop mental and spiritual powers. Yoga practice tone up the pelvic organs and 
muscles and promote good circulation. Minor structural and functional defects of the 
body can be rectified by the systemic practice of Yogasanas and Pranayamas  
 Women should keep in mind that they should not do asanas during their 
monthly menstrual period.After the period ends, asanas can be practiced andit will 
give a lot of benefits.  
The following  aasanas are advised in menorrhagia:    
 Trikonasana 
 Vajrasana 
 Halasana 
 Patchimothasana 
 Parvadhasana 
 Garudasana 
 Savasana 
 Ardha chandrasana 
 
 Uttanasana 
 Baddhakonasana 
 Sarvagasana(39) 
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Pranayamam - Abdominal breathing and Naadi shodhana 
Precautions – Avoid strenuous and inverted postures while menstruating. 
NIRAIVU (RESTORATION) : 
LIFESTYLE MODIFICATION:  
In ―THERAIYAR PINIANUGAAVITHI” certain traditional principles of 
prevention are mentioned. In addition ―SARABENDHIRAR” prescribes a few rules 
to be followed at the time of the menstruation.  
DONT’S 
 
 Avoid makeup 
 Avoid anchanam for the eyes  
 Avoid purgatives  
 Avoid heavy works  
 Avoid activities like jumping, too much of crying and laughing  
 Avoid emotional stress  
 Avoid tobacco chewing  
 Avoid strong tea and coffee  
 Avoid fast food and spicy items  
 Avoid excess salt, spices, sweets and fat foodstuffs  
DO’S  
 Advice to take plenty of fibre rich foods like fruits, greens, nuts and 
leavy vegetables.  
 Advice to take Iron enriched greens, vegetables and cereals. Iron 
containing vegetables and fruit supplementation (100mg/day) prevents 
anaemia.  
 Vitamin C enriched diet which ensures Iron absorption and capillary 
constriction.  
 Daily consumption of dates.  
 Salt restricted diet.  
 Reducing caffeine and sugar.  
 Hip bath – Hot water hip bath as routine practice should be taken for 
10mts.  
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 Gentle exercises such as deep breathing exercises, progressive muscle 
relaxation, range-of-motion exercises to keep the joints mobile and 
slow relaxed walking promotes good oxygenation and circulation and 
can even help to increase energy.  
 Hygiene should be advised during menstruation.  
Prevention of disease is also achieved by following proper diet and good habits. 
Proper diet not only means the intake of nutritious diet but also abstinence from edible 
substances which are injurious to health.  
The line of treatment aims at bringing back the affected thaathus to normal by the 
administration of internal medicine NAAVAL NEI
(40)
. 
Finally, assurance of the patient gives her a moral boost thereby speeding up the 
recovery. 
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MODERN ASPECT 
 FEMALE REPRODUCTIVE SYTEM 
                 The female reproductive system consists of internal and external 
genitalia.The main functions of female reproductive system are  
 Production of sex hormones 
 Production of functioning gametes [ova] 
 Support & protection of developing embryo 
EXTERNAL GENITALIA 
                    The external female genitalia are referred to as vulva. It consists of the 
following structures namely, 
 Mons pubis 
 Labia majora 
 Labia minora 
 Clitoris 
 Opening of the urethra (Meatus) 
 Hymen 
 Perineum 
 The vestibule is the space into which the vagina and urethra open. The 
urethra opens just anterior to the vagina. 
 The vestibule is bordered by a pair of thin, longitudinal skin folds 
called  
labia minora. 
 Lateral to the labia minora two prominent rounded folds of skin called 
the 
labia majora. 
 The two labia majora unite anteriorly in an elevation of tissue over the 
pubic symphysis called the mons pubis. The lateral surface of the labia majora and 
the surface of the mons pubis are covered with coarse hair. 
 The medial surface of the labia majora are covered with numerous 
sebaceous and sweat glands. The space between  the labia majora is called 
the pudendal cleft. 
 A small erectile structure is called the clitoris is located in the anterior 
margin of the vestibule. The two labia minora unite over the clitoris to form 
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a fold of skin called the prepuce
(41)
. 
 The Perineum is bounded above by the inferior surface of  the pevic 
floor, below by the skin between the buttocks and thighs. Laterally by 
the ischiopubic rami, ischial tuberosities and sacrotuberous ligaments 
and posteriorly by the coccyx
(42)
. 
INTERNAL GENITALIA 
                    The internal reproductive organs situated in the pelvis between the 
bladder and rectum. They are held in space within the pelvis by a group of ligaments. 
The internal genitalia includes 
 VAGINA 
 CERVIX 
 UTERUS 
 FALLOPIAN TUBES 
 OVARIES 
VAGINA 
 The vagina is a muscular, hollow tube that extends from the vaginal 
opening to the  cervix of the uterus. It also is known as the birth canal. 
 It is a fibro muscular tube of about 10cm long. 
 It is female organ of copulation and allows menstrual flow and child 
birth. 
 In young females it is covered by a thin mucous membrane called 
hymen
(43)
. 
CERVIX 
 The cervix is the lower, narrow portion of the uterus where it joins 
with the top end of the vagina. 
 During menstruation, the cervix stretches open slightly to allow the 
endometrium to be shed. 
 During childbirth, contractions of the uterus will dilate the cervix up to 
10 cm in diameter to allow the child to pass through
(44)
. 
UTERUS 
 The uterus is a hollow, pear-shaped organ which is divided into parts 
namely Cervix, which is the lower part that opens into the vagina, and the 
main body of the uterus, called the corpus. 
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 The uterine wall is composed of three layers, 
 Outer serous layer or perimetrium, 
 Middle muscular layer or myometrium, 
 Innermost endometrium. 
 The endometrium consists of simple columnar epithelial cells with 
underlying connective tissue layer. The superficial part of endometrium is sloughed 
down during menstruation. 
POSITION OF UTERUS  
 Its normal position is anteversion and anteflexion. The uterus usually 
inclines to the right (dextrorotataion) so that the cervix is directed to 
the left (levorotation) and comes in close relation with the left ureter. 
MEASUREMENT OF UTERUS  
 The uterus measures about 8cm long, 5cm wide at the fundus and its 
walls are about 1.25cm thick. Its weight varies from 50-80 gm.   
PARTS OF THE UTERUS 
 Body or corpus 
 Isthmus 
 Cervix(45) 
FALLOPIAN TUBES 
 There are two uterine tubes also called uterine tubes or oviducts. 
 One uterine tube is associated with each ovary. 
 The uterine tubes extend from the ovaries to the uterus. They open pear 
the ovary to receive the oocyte and the opening is surrounded by long 
thin processes called fimbriae. 
 As soon as oocyte is ovulated, it comes into contact with the surface of 
the fimbriae and the cilia on the fimbrial surface sweep the oocyte into 
the uterine tube. 
 Fertilization usually occurs in the uterine tube near the ovary(46). 
OVARIES 
 The two ovaries are small oval shaped organs aattached to ligaments 
that suspend them in the pelvic cavity and from the ligament of the 
uterus. 
 The suspensory ligament extends from each ovary to the lateral body 
wall and the ovarian ligament attaches the ovary to the uterus.  
37 
 
 A layer of visceral peritoneum called tunica albuginea covers the 
ovary. 
 The outer cortex of the ovary is made up of dense connective tissue 
containing ovarian follicles.Each of the ovarian follicles contains an 
oocyte the female germ cell
(47)
. 
PHYSIOLOGY OF MENSTRUAL CYCLE 
MENSTRUATION  
DEFINITION  
Menstruation is the visible manifestation of cyclic physiologic uterine 
bleeding due to shedding of the endometrium following invisible interplay of 
hormones mainly through hypothalamo-pituitary-ovarian axis.  
For the menstruation to occur, the axis must be actively coordinated, 
endometrium must be responsive to the ovarian hormones (oestrogen and 
progesterone) and the outflow tract must be patent. 
DURATION OF MENSTRUATION CYCLE  
The period extending from the beginning of a period (mens) to the beginning 
of the next one is called menstrual cycle.  
The first menstruation (menarche) occurs between 11-15 years with a mean of 
13 years. It is more closely related to bone age than to chronological age. For the past 
couple of decades, the age of menarche is gradually declining with improvement of 
nutrition and environmental condition.  
Once the menstruation starts, it continues cyclically at intervals of 21-35 days 
with a mean of 28 days. Physiologically, it is kept in abeyance due to pregnancy and 
lactation. Ultimately, it ceases between tne age 45-50 when menopause sets in. 
The duration of menstruation is about 4-5 days and the amount of blood loss is 
estimated to be 20-80ml with an average of 35ml. Nearly 70% of total menstrual 
blood loss occurs in the first 2 days. 
CONTENTS OF MENSTRUAL DISCHARGE  
     The menstrual discharge consists mainly of dark altered blood, mucus, 
vaginal epithelial cells, fragments of endometrium, prostaglandins, enzymes and 
bacteria
(48)
. 
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MENSTRUAL SYMPTOMS  
In majority, apart from bleeding from vaginam there is no symptom. 
Initially, it begins as pink discharge but on day 2 and 3 it becomes dark red. 
In teenagers or nulliparous, there may be associated tolerable colicky 
pain at the beginning due to uterine contraction. 
If the pain is of sufficient magnitude so as to incapacitate the day-to-
day activities, it is called dysmenorrhoea. 
There may be premonitory symptoms such as  
 Pelvic discomfort   
 Backache   
 Fullness of the breasts or mastalgia  
 Headache or depression  
 Constipation or diarrhea  
 Appetite changes or food carvings  
 Irritability or mood swings 
 
If these premonitory symptoms are predomimant, these are grouped into a 
syndrome called ―Premenstrual syndrome‖(49). 
CHANGES DURING MENSTRUAL CYCLE  
During each menstrual cycle, series of changes occur in ovary, uterus, vagina 
and in cervix.  
 
OVARIAN CHANGES DURING MENSTRUAL CYCLE  
It occurs in two phases, which includes  
 Follicular phase  
 Luteal phase  
UTERINE CHANGES DURING MENSTRUAL CYCLE  
Along with ovarian changes, uterine changes also occur simultaneously. This 
changes in uterus takes place in three phases which includes  
 Menstrual phase   
 Proliferative phase  
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 Secretory phase  
CHANGES IN VAGINA AND CERVIX DURING MENSTRUAL CYCLE  
 Proliferative phase  
 Secretory phase(50) 
PHASES OF MENSTRUAL CYCLE 
                       The day count for menstrual cycle begins on the first day of 
menstruation when blood starts to come out of the vagina. In this section, the length 
of menstrual cycle has been assumed to be 28 days (which is the average among 
women). The entire duration of a Menstrual cycle can be divided into four main 
phases: 
1. Menstrual phase (From day 1 to 5) 
2. Follicular phase (From day 1 to 13) 
3. Ovulation phase (Day 14) 
4. Luteal phase (From day 15 to 28) 
MENSTRUAL PHASE (day 1-5) 
                 Menstrual phase begins on the first day of menstruation and lasts till the 5th 
day of the menstrual cycle.  
The following events occur during this phase: 
 The uterus sheds its inner lining of soft tissue and blood vessels which 
exits the body from the vagina in the form of menstrual fluid. 
 Blood loss of 10 ml to 80 ml is considered normal. 
 This phase is also known as destructive phase or phase of bleeding. 
 During this phase,the uterus sheds its inner lining of soft tissue and 
blood vessels which exits the body from the vagina in the form of 
menstrual fluid. 
FOLLICULAR PHASE (day 1-13) 
             This phase is also known as preovulatory phase or proliferative phase or 
estrogen phase    
 This phase also begins on the first day of menstruation, but it lasts till 
the 13th day of the menstrual cycle. The following events occur 
during this phase: 
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 The pituitary gland secretes a hormone that stimulates the egg cells in 
the ovaries to grow. 
 One of these egg cells begins to mature in a sac-like-structure called 
follicle. It takes 13 days for the egg cell to reach maturity. 
 While the egg cell matures, its follicle secretes a hormone that 
stimulates the uterus to develop a lining of blood vessels and soft 
tissue called endometrium. 
OVULATION PHASE (day 14) 
                      On the 14th day of the cycle, the pituitary gland secretes a hormone that 
causes the ovary to release the matured egg cell. The released egg cell is swept into 
the fallopian tube by the cilia of the fimbriae. Fimbriae are finger like projections 
located at the end of the fallopian tube close to the ovaries and cilia are slender hair 
like projections on each Fimbria. 
LUTEAL PHASE (day 15-28) 
             The phase is also known as secretory phase or premenstrual phase or 
progestational phase.    
 This phase begins on the 15th day and lasts till the end of the cycle. 
The following events occur during this phase: 
 The egg cell released during the ovulation phase stays in the fallopian 
tube for 24 hours. 
 If a sperm cell does not impregnate the egg cell within that time, the 
egg cell disintegrates. 
 The hormone that causes the uterus to retain its endometrium gets 
used up by the end of the menstrual cycle. This causes the menstrual 
phase of the next cycle to begin
(51)
. 
HORMONES REGULATING THE CYCLE: 
  A normal menstrual cycle depends on cyclical ovarian steroid secretions 
which in turn are controlled by the pituitary and the hypothalamus, and to some extent 
by the thyroid and adrenal glands. So the the hypothalamo-pituitary-ovarian axis is 
important. The following hormones play the major role,   
 Gonadotropin releasing hormone (GnRH) 
 Follicle stimulating hormone (FSH)   
 Luteinising hormone (LH)   
 Oestrogen   
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 Progesterone. 
GONADOTROPIN RELEASING HORMONE (GnRH): 
  Gonadotropin releasing hormone is secreted by the hypothalamus which 
modulates the neural control of FSH and LH by the anterior pituitary.  GnRH is 
released in a pulsatile manner.  In preovulatory phase it pulses every 60 minutes but 
slows down in luteal phase to one in 3 hours. GnRH is continuous in males but 
pulsatile in females.  The hypothalamus is controlled by higher cortical centers 
(temporal lobe). Emotional upsets stimulate or depress the H-P-O axis and disturb the 
menstrual cycles. 
ANTERIOR  PITUITARY  HORMONE 
FOLLICLE  STIMULATING  HORMONE (FSH)   
   It is secreted by the beta cells of anterior pituitary gland. FSH controls the 
ripening of the primordial follicles and in combination with the luteinizing hormone 
activates the secretion of estrogen.  Its action starts after cease of menstruation and 
reaches the  peak by 7th day and then declines to disappear around 18th day. Another 
small peak occurs in the premenstrual phase.  Low FSH causes defective 
folliculogenesis and short or defective corpus luteal phase. 
 LUTEINIZING HORMONE (LH) 
                       It is secreted by the beta cells of anterior pituitary gland. In 
combination with FSH it activates the secretion of estrogen.  
                       It brings about maturation of the ovum and causes ovulation.  
                       LH stimulates the completion of the reduction division of the 
oocyte.Following ovulation it produces luteinization of the granulosa and the theca 
cells and initiates progesterone secretion. The LH surge precedes ovulation by 24 to 
36 hours. 
OVARIAN HORMONES 
 OESTROGEN   
                        The main source of oestrogen are the theca end granulosa cells of the 
graafian follicles and corpus luteum,while the adrenal cortex is the secondary source.  
                        Its level rises 6 to 7 days before ovulation and reaches the peak 2 days 
before ovulation and then declines.  
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                        It increases uterine vascularity and regenerates the endometrium after 
menstruation and is responsible for the proliferative hyperplasia of the endometrium. 
 PROGESTERONE   
                         The corpus luteum is the main source of progesterone. The level rises 
after ovulation and reaches peak at mid luteal phase. With the degeneration of the 
corpus luteum its level falls and brings about menstruation.  
                          If pregnancy occurs the corpus luteum continues to enlarge and 
secrete progesterone. The high level of the hormone prevents menstruation and leads 
to amenorrhoea of pregnancy
(52)
.  
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MENORRHAGIA 
SYNONYM                           
HYPERMENORRHOEA 
MENOSTAXIS 
DEFINITION: 
Menorrhagia is defined as cyclic bleeding at normal intervals : the bleeding is 
either excessive in amount (> 80ml) or duration (> 7 days)  or both. The term 
Menostaxis is often used to denote prolonged bleeding. 
.CAUSES  
Menorrhagia has some underlying pathology- organic or functional.  
ORGANIC CAUSES  
 Pelvic  
 Systemic  
 Endocrinal  
 Blood dyscrasias  
 Emotional upse 
PELVIC PATHOLOGY  
Due to congestion, increased surface area or hyperplasia of the endometrium.  
 
 Fibroid uterus  
 Fibroid polyp  
 Adenomyosis  
 Chocolate cyst  
 PCOD  
 Pelvic endometriosis  
 IUCD inutero  
 Chronic tubo-ovarian mass  
 Tubercular endometritis (early cases)  
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 Pelvic inflammatory diseases  
 Retroverted uterus – due to congestion  
 Granulosa cell tumour of the ovary 
SYSTEMIC CAUSES  
 Congestive cardiac failure  
 
 Severe hypertension 
ENDOCRINAL CAUSES  
 Hypothyroidism  
 Initial stages of Hyperthyroidism  
BLOOD DYSCRASIAS  
 Idiopathic thrombocytopenic purpura  
 Leukaemia  
 Von Willebrand‘s disease  
 Platelet deficiency (thrombocytopenia) 
FUNCTIONAL CAUSES  
Due to disturbed hypothalamo- pituitary- ovarian- endometrial axis  
 
COMMON CAUSES OF MENORRHAGIA  
 Dysfunctional uterine bleeding  
 Fibroid uterus  
 Adenomyosis  
 Chronic tubo-ovarian mass 
DYSFUNCTIONAL UTERINE BLEEDING  
DUB is defined as a state of abnormal uterine bleeding without any clinically 
detectable organic, systemic and iatrogenic cause. In a large number of patients, 
menorrhagia is not associated with any structural abnormality, disease in the pelvis or 
evidence either of general or endocrine disease.  
The aetiology is purely hormonal and that the hypertrophy and the hyperplasia 
of the endometrium are induced by a high titre of oestrogen in the circulating blood.  
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The prevalence varies widely but an incidence of 10% amongst new patients 
attending the out-patient seems logical. 
PATHO –PHYSIOLOGY  
The current concept concludes that the abnormal bleeding is most likely due to 
local causes in the endometrium. There is some disturbance of the endometrial blood 
vessels and capillaries and coagulation of blood in and around blood vessels. These 
are probably related to alteration in the ratio of endometrial prostaglandins which are 
delicately balanced in haemostasis of menstruation. 
The endometrial abnormalities may be primary or secondary to inco-ordination in the 
hypothalamo-pituitary-ovarian axis. It is thus more prevalent in extremes of 
reproductive period – adolescence and premenopause or following childbirth and 
abortion. 
Emotional influences, worries, anxieties or sexual problems sometimes are enough to 
disturb the normal hormonal balance
(53)
. 
SYMPTOMS OF MENORRHAGIA: 
Saturating multiple sanitary pads or tampons per hour 
Requiring two sanitary pads to contain uterine bleeding 
Waking up at night to change sanitary pads or tampons 
Prolonged bleeding that lasts beyond a week 
Passing large blood clots 
Inability to engage in routine daily activities 
Fatigue and weakness (signs of anemia) 
Tiredness 
Shortness of breath. 
Head ache 
Lower abdominal pain 
DIAGNOSIS: 
Blood tests 
 A sample of blood may be evaluated for iron deficiency (anemia) and other 
conditions, such as thyroid disorders or blood-clotting abnormalities. 
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Pap test 
  In this test, cells from the cervix are collected and tested for infection, 
inflammation or changes that may be cancerous or may lead to cancer. 
Endometrial biopsy 
 Take a sample of tissue from the inside of the uterus to be examined by a 
pathologist. 
Ultrasound scan  
  This imaging method uses sound waves to produce images of the uterus, 
ovaries and pelvis. 
Based on the results of the initial tests, doctor may recommend further tests : 
Sonohysterogram 
 During this test, a fluid is injected through a tube into the uterus by way  of  
vagina and cervix and then uses ultrasound to look for problems in the lining of  the 
uterus. 
Hysteroscopy 
  This exam involves inserting a tiny camera through the vagina and cervix 
into the uterus, which allow to  see the inside of the  uterus. 
MANAGEMENT  
 General measures to improve the health status of the patient. Advice 
regarding proper diet, adequate rest during menses, oral administration 
of haematinics, vitamins and protein supplements and to maintain a 
menstrual calendar noting duration and extent of blood loss.  
 Treat the cause.   
In women suffering from DUB, consider:  
 Oral non-steroidal anti-inflammatory drugs like mefenamic acid 500 
mg t.d.s along with antacids. Other drugs in the category include 
naproxen, ponstan and ibuprofen  
 Cyclic oral contraceptive pills.  
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 Oral progesterone - When taken for 10 or more days of each menstrual 
cycle, the hormone progesterone can help correct hormone imbalance 
and reduce menorrhagia.  
 The hormonal IUD (Mirena) - This intrauterine device releases a type 
of progestin called levonorgestrel, which makes the uterine lining thin 
and decreases menstrual blood flow and cramping.  
 Hysterectomy in selected cases.  
THERAPEUTIC MEASURES  
This includes  
 Removal of an offending intrauterine contraceptive device.  
 Myomectomy or hysterectomy for uterine fibroids.  
 Wedge resection or hysterectomy for adenomyosis of the uterus.  
 Laparoscopic lysis of adhesions for chronic PID. 
 
 Electrocautery or laser vaporization of endometriosis and drainage of 
chocolate cysts in pelvic endometriosis.  
 Hysterectomy with or without removal of the adnexa as per the age 
and the individual needs of the patient.  
 In patients suffering from bleeding disorders, a haematologist‘s 
opinion should be sought
(54)
. 
Dilation and curettage (D&C)  
   In this procedure, opens (dilates) cervix and then scrapes or suctions tissue 
from the lining of uterus to reduce menstrual bleeding. Although this procedure is 
common and often treats acute or active bleeding successfully, may need additional 
D&C procedures if menorrhagia recurs. 
Uterine artery embolization  
 For women whose menorrhagia is caused by fibroids, the  goal of this 
procedure is to shrink any fibroids in the uterus by blocking the uterine arteries and 
cutting off their blood supply. 
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   During uterine artery embolization, the surgeon passes a catheter through the 
large  artery in the thigh (femoral artery) and guides the uterine arteries, where the 
blood vessel is injected with microspheres made of  plastic. 
Focused ultrasound ablation 
Similar to uterine artery embolization, focused ultrasound ablation treats 
bleeding caused by fibroids by shrinking the fibroids. This procedure uses ultrasound 
waves to destroy the fibroid tissue. There are no incisions required for this procedure. 
Myomectomy 
 This procedure involves surgical removal of uterine fibroids. Depending on 
the size, number and location of the fibroids. 
Endometrial ablation  
Using a variety of techniques, permanently destroys the lining of the uterus 
(endometrium). After endometrial ablation, most women have much lighter periods.  
Endometrial resection 
 This surgical procedure uses an electrosurgical wire loop to remove the lining 
of the uterus. Both endometrial ablation and endometrial resection benefit women 
who have very heavy menstrual bleeding.  
Hysterectomy 
 Hysterectomy — surgery to remove the uterus and cervix — is a permanent 
procedure that causes sterility and ends menstrual periods. 
COMPLICATIONS: 
Iron deficiency anaemia 
Tiredness 
Psychological disturbances 
Poor concentration
(55)
. 
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TRIAL DRUG 
NAAVAL  NEI 
INGREDIENTS  
 Naaval pattai (Syzygium cumini)                   : 1400 gm 
 Perumarathupattai (Sterculia foetida)                    : 10.2 gm 
 Aavarai arisi (Cassia auriculata)                       : 10.2 gm 
 Aavarai vaerpattai (Cassia auriculata)              : 10.2 gm 
 Kottam(Costus speciosus)                                 : 10.2 gm 
 Lavanga pattai ( Cinnamomum verum)            : 10.2 gm 
 Karkadaka singi (Rhus succedanea)                 : 10.2 gm 
 Athimadhuram (Glycyrrhiza glabra)                : 10.2 gm 
 Athividaiyam (Aconitum heterophyllum)       : 10.2 gm 
 Sadamanjil (Nardostachys grandiflora)           : 10.2 gm 
 Kookai neer (Maranta  arundinacea)               : 10.2 gm 
 Thevathaaram (Cedrus deodara)                      : 10.2 gm 
 Sirunaagappoo (Mesua nagassarium)              : 10.2 gm 
 Nilappanai kilangu ( Curculigo orchioides)      : 10.2 gm 
 Nannari vaer (Hemidesmus indicus)                : 10.2 gm 
 Ghee                                                                      : 2 Litres 
STANDARD OPERATIVE PROCEDURE 
SOURCE OF RAW DRUGS: 
    The required raw drugs are obtained  from a well reputed indigenous raw drug 
shop. The raw drugs taken for study was authenticated  by the Pharmacognosist of 
Gunapadam Dept, Govt. Siddha  Medical College, Chennai 600106. 
PURIFICATION OF RAW DRUGS: 
                  Raw drugs are purified as mentioned in Sikitcha Ratna Deepam Sarakku 
Suthi Muraigal. 
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PREPARATION: 
                   First purified  Naaval pattai is made into kudineer, in that the above raw 
drugs are made in to fine powder and made into karkam with cow‘s milk.Then the 
karkam and sufficient amount of cow‘s ghee is added to kudineer and boiled,still it 
comes to nei consistency and stored in a air-tight container. 
DRUG STORAGE: 
                    The trial drug is stored in clean dry air tight container and it is dispensed 
to the patients in pockets. 
DOSE                    :  5ml ; tds after food.  
DURATION         :  For one Mandalam (48 days) 
REFERENCE      :  AATHMARATCHAMIRTHA VAITHIYA SAARA   
          SANGIRAGAM (PART II) Page No :252
(56) 
PROPERTIES OF TRIAL DRUGS 
    DRUG NAME 
 
FAMILY 
 
TASTE POTENCY PIRIVU 
 
   ACTION 
 
Naaval pattai 
(Syzygium cumini) 
Myrtaceae 
 
Thuvarpu Cold Kaarppu Astringent  
Stomachic
(57) 
 
 Perumarathpattai 
(Sterculia foetida) 
Malvaceae 
 
Kaippu Heat Kaarppu Laxative
(58) 
Aavarai arisi 
(Cassia auriculata) 
Fabaceae 
 
Thuvarpu Cold Inippu Refrigerant
(59) 
Aavarai vaerpattai 
(Cassia auriculata) 
Fabaceae 
 
Thuvarpu Cold Inippu  Astringent 
 Tonic
(60) 
Kostham 
(Costus speciosus) 
Zingiberaceae 
 
Kaippu 
 
Heat Kaarppu Stomachic, 
Tonic
(61)
.
 
 
Lavanga pattai Lauraceae Kaarppu Cold Inippu Carminative
(62) 
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(Cinnamomum verum)   
Karkadaka singi 
(Rhus succedanea) 
Anacardiaceae 
 
Thuvarpu Heat Kaarppu Astringent  
Tonic
(63) 
 
Athimadhuram 
(Glycyrrhiza glabra) 
 
Fabaceae 
 
Inippu 
 
Cold  Inippu 
 
Tonic 
Emollient 
Demulcent
(64) 
 
Athividaiyam 
(Aconitum 
heterophyllum) 
Ranunculaceae Kaippu 
 
Heat Kaarppu Stomachic 
Tonic 
Astringent
(65)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sadamanjil 
(Nardostachys 
grandiflora) 
Caprifoliaceae Kaarppu Heat Kaarppu Anti 
spasmodic
(66) 
Kookai neer 
(Maranta arundinacea) 
Marantaceae Inippu 
 
Cold Inippu 
 
Demulcent 
Nutrient
(67) 
 
Thevathaaram 
(Cedrus deodara) 
Pinaceae Thuvarpu Heat Kaarppu Astringent
(68) 
Sirunaagappoo 
(Mesua nagassarium) 
Calophyllaceae Thuvarpu Cold Kaarppu Astringent
(69) 
Nilappanai kilangu 
(Curculigo orchioides) 
Hypoxidaceae Inippu 
 
Cold Inippu 
 
Astringent 
Tonic 
Carminative
(70) 
Nannari vaer 
(Hemidesmus indicus) 
Apocynaceae Inippu 
 
Cold Inippu 
 
Tonic 
Demulcent 
Alterative
(71) 
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஥ாவல் ெட்டட : 
ஆசினச஥ாய் காசம் அசிர்க்கபஞ்சு யாசயிட஦ 
சகசன௅று ஧ா஬ கிபகச஥ாய் – ச஧சரின 
நாயினங்க ஬ாஞ்ச஦நிவ் யன்஧ிணிவன ஬ாசநகும் 
஥ாயற௃று ஧ட்டடனத ஦ால்(72). 
அசிர்க்கரம்  –  வ஧ன௉ம்஧ாடு(73).  
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TRIAL DRUG PHOTOS 
DRUGS OF NAAVAL NEI 
            
           
                      
Syzygium cumini Sterculia foetida 
Seeds of cassia auriculata Cinnamomum verum  
vvverum
Costus speciosus Mesua ferrea 
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Glyccyrrhiza glabra 
Aconitum heterophyllum 
Nardastachys 
grandiflora Cedrus deodara 
Curculigo orchioides Hemidesmus indicus 
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TRIAL DRUG 
NAAVAL NEI 
 
                              
 
 
 
 
 
Maranta arundinacea Rhus succedanea 
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MATERIALS AND METHODS 
 
STUDY DESIGN: 
 The clinical trial on Pitha Perumbadu (Menorrhagia) was decided to conduct 
as an open label study. 
The study was approved by Institutional Ethics Committe (IEC) and the 
approved number is GSMC-CH-ME-4/2015/005. The stydy was registered in Clinical 
Trials Registry – India (CTRI) and the reference Number is CTRI/2017/05/008615. 
STUDY CENTER: 
 The entire study was conducted on patients at Out Patients Department of 
Govt Siddha Medical College, Chennai in the premises of Arignar Anna Government 
Hospital for Indian Medicine and Homeopathy, Arumbakkam, Chennai – 106, during 
the period of 2015 - 2017. 
POPULATION: 
 The population consists of all patients were attending the OPD of Aringnar 
Anna Hospital, Arumbakkam, Chennai – 106. Sample consists of Pitha Perumbadu 
who satisifying the inclusion and exclusion criteria mentioned below: 
SAMPLE SIZE:  
              20 patients in the age group 15-50 years. 
STUDY DRUG: 
              NAAVAL NEI – 5 gm tds  for 1 mandalam (48 days) 
SELECTION CRITERIA: 
              The population of Pittha perumbadu rogam patients with the following signs 
and symtoms are taken into the clinical trial. 
 Excessive menstruation 
 Prolonged menstruation 
 Presence of blood clots in menstrual bleeding 
 Lower abdominal pain 
 Low back ache 
 Giddiness during menstruation 
 Headache during menstruation 
 Tiredness during menstruation 
 USG report with fibroid uterus or  PCOD.  
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EXCLUSION CRITERIA: 
 Diabetis mellitus 
 Hypertension 
 Patient having IUCD 
 Abortion 
 Thromobocytopenic purpura  
 Coagulopathy  
 Severe anaemia (<6 gm) 
 Hypothyroidism 
 Vulnearable populations such as 
HIV positive 
TB affected individuals 
WITHDRAWAL CRITERIA: 
 Intolerance to the drug and development of any serious 
adverse effect during trial. (If  ADR  is reported the patient 
will be directed to RPC) 
 Patient turning unwilling during course of trial.   
 Poor compliance. 
 Any other acute illness which needs a rescue medication. 
 
EVALUATION OF CLINICAL PARAMETERS: 
 
The case sheet proforma for Pitha Perumbadu was prepared based on Siddha 
diagnostic metholodgy with necessary modern techniques. 
Patients are clinically evaluated by the following parameters 
A. HISTORY TAKING: 
Age, Occupation, Socio economic status, Complaints and its duration, Previous 
illness, Family history, Personal habits were recorded in the case sheet for every 
patient at the time of first visit to the OP. 
B. INVESTIGATION: 
At the patients were subjected to the laboratory investigations. 
This was carried out regularly before and after treatment. 
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 BLOOD: 
             TC, DC, ESR, Hb, Blood Sugar ( Fasting and Post Prandial ), 
Serum cholesterol, Blood Urea, Bleeding time & Clotting time, 
Thyroid Profile. 
 URINE: 
Albumin, Sugar, Deposits. 
 USG For Abdomen and Pelvis. 
CLINICAL DIAGNOSIS BASED ON SIDDHA SYSTEM: 
 The paramaters used to diagnosis the DISEASE PITTHA PERUMBADU 
ROGAM  based on Siddha System. 
 Porial arithal 
 Pulanaal arithal 
 Vinaathal 
 Envagai Thervugal 
 Uyir thathukal 
 Udal thathukal 
 Neerkuri 
 Neikuri. 
CONDUCT OF THE STUDY: 
 
 Pittha Perumbadu Rogam patients satisfying the inclusion and exclusion 
criteria will be included in the trial. Informed consent form will be obtained from the 
patients. A day before starting the trial treatment, pacifying the mukkutram by 
purgation will be carried out by Agasthiya Kuzhambu-100 mg with chukku kasayam 
at empty stomach in the early morning. 
  The trial drugs will be issued for 7 days at a time and clinical assessment will 
be carried out 7days once. 
CASE SHEET PROFORMA:  
  All the clinical signs and symptoms of Pittha Perumbadu Rogam, history of 
present and past illness, personal history, menstrual history, family history, personal 
habbits and occupation were recorded. Lab investigations and prognosis were 
recorded for analysis. 
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TRIAL MEDICINE: 
NAAVAL NEI 
DOSE                :     5 gm; thrice a day; After Food. 
 INDICATION   :     Menorrhagia 
 REFERENCE      :     AATHMARATCHAMIRTHA VAITHIYA  SAARA 
       SANGIRAGAM(PARTII) PAGE NO :252. 
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RESULTS AND OBSERVATION 
Pitha Perumbadu Rogam was carried out in 20 patients in the out patient  Post 
Graduate department, Pothu Maruthuvam, Govt,Siddha medical College, Chennai-
106 attached to Aringnar Anna Government Hospital during 2014 - 2017 analysed. 
 
The observations were made and tabulated with following criteria: 
 
 Distribution of Age 
 Occupational Distribution 
 Distribution of Marital status 
 Distribution of Socio-economic status 
 Distribution of Food habits 
 Distribution of Paruvakkalam 
 Distribution of Thinai 
 Distribution of Mukkutram 
    - Vathakutram 
          - Pittha kutram 
          - Kabha kutram 
 Distribution of Udal Thaathukal 
 Distribution of Envagai thervugal 
            - Naadi 
            - Miscellaneous 
            - Neerkuri 
 Signs and Symptoms before and  after treatment 
 Number of pads used before and after treatment 
 Hemoglobin level before and after treatment 
 Bleeding time and Clotting time before and after treatment 
 Gradation of result. 
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AGE DISTRIBUTION 
 
S.NO AGE NUMBER      OF 
CASES/20 
PERCENTAGE 
(%) 
1. 15-25 YEARS 7 35 
2. 26-35 YEARS 6 30 
3. 36-45 YEARS 6 30 
  4. 46-50 YEARS 1 05 
  
 INFERENCE:                
 5% of patients were in the age group 46-50, 30% of patients were in the age 
group 36-45, 30% of patients were in the age group 26-35 and 35% of patients were 
in the  age group of 15-25. 
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OCCUPATION 
 
 
S.NO 
 
  NATURE OF WORK 
  
 NO.OF CASES/20            
 
PERCENTAGE 
 
    1. 
 
       STUDENT 
 
2 
 
10% 
 
    2. 
 
 
      WORKING WOMEN 
 
 
6 
 
30% 
 
 
    3. 
 
       HOUSE WIFE 
 
12 
 
60% 
 
    
INFERENCE 
60% of patients were house wife, 30% of patients were working women and 
10% were student. 
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MARITAL STATUS 
  
 
 S.NO 
 
         STATUS            
 
NO.OF CASES/20 
 
PERCENTAGE 
    
     1. 
 
         
           MARRIED 
 
 
15 
 
 
75% 
 
 
     2. 
 
         UNMARRIED 
 
5 
 
25% 
                                                                                                                                                 
             
   
 
INFERENCE 
75% of patients were married and 25% of patients were unmarried.  
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 SOCIO-ECONOMIC STATUS  
 
S.NO STATUS 
INCOME  PER ANNUM 
NO.OF CASES/20 PERCENTAGE 
    
    1. 
LOWER 
(UPTO 2 LAKHS/ANNUM) 
 
6 
 
30% 
     
    2. 
MIDDLE 
(2-5 LAKHS/ANNUM) 
 
9 
 
45% 
     
    3. 
UPPER 
(ABOVE 5 LAKHS/ANNUM) 
 
5 
 
25% 
 
 
INFERENCE 
                  30% of patients were from lower income group, 45% of patients were 
from middle income group and 25% were from upper income group 
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FOOD HABITS 
 
 
S.NO 
     
    FOOD HABITS 
 
NO.OF CASES/20 
 
PERCENTAGE 
    
     1. 
         
         VEGETARIAN 
 
6 
 
30% 
      
     2. 
        
           MIXED DIET 
 
14 
 
70% 
 
 
 
INFERENCE 
                    70% of patients belong to mixed diet habit and 30% of patients belong  to 
vegetarian diet habi 
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PARUVAKKALAM 
 
S.N
O 
 
KAALAM 
 
NO.OF 
CASES/
20 
 
PERCENTAGE 
% 
 
1. 
 
KAAR KAALAM(AAVANI,PURATTAASI) 
(AUG 16 - OCT 15) 
 
5 
 
25 
 
2. 
 
 
KOOTHIRKAALAM(AIPPASI,KAARTHIGAI) 
(OCT 16 – DEC 15) 
 
0 
 
0 
 
3. 
 
MUNPANIKAALAM(MAARKALI,THAI) 
(DEC 16 – FEB 15) 
 
3 
 
15 
 
4. 
 
PINPANIKAALAM(MAASI,PANGUNI) 
(FEB 16 – APR 15) 
 
8 
 
40 
 
5. 
 
ELAVENILKAALAM(SITHIRAI,VAIKAASI) 
(APR 16 – JUN 15) 
 
2 
 
10 
 
6. 
 
MUTHUVENILKAALAM(AANI,AADI) 
(JUN 16 – AUG 15) 
 
2 
 
10 
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INFERENCE 
                 10% of patients were reported in Elavenilkaalam and Muthuvenilkaalam, 
25% of patients were reported in Kaarkaalam  15% of patients were Munpanilkaalam 
and 40% of patients were reported in pinmanikaalam. 
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THINAI 
 
S.NO 
           
            THINAI 
 
NO.OF CASES/20 
 
PERCENTAGE 
 
   1. 
 
           KURINJI 
 
0 
 
0% 
 
   2. 
 
           MULLAI 
 
0 
 
0% 
 
   3. 
 
           MARUTHAM 
 
4 
 
20% 
 
   4. 
 
          NEITHAL 
 
16 
 
80% 
 
   5. 
 
          PAALAI 
 
0 
 
0% 
 
 
INFERENCE 
                  The patients about 80% were from Neithal thinai and 20% of the patients 
were from Marutham thinai. 
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MUKKUTRAM :  VATHA KUTTRAM 
 
S.NO 
 
TYPES OF VATHAM 
 
NO.OF 
CASES/20 
 
PERCENTAGE    
1 PRANAN 4 20% 
2 ABANAN 20 100% 
3. UDHANAN 3 15% 
4. VIYANAN 20 100% 
5. SAMAANAN 12 60% 
6. NAAGAN 0 0% 
7. KOORMAN 3 15% 
8. KIRUGARAN 0 0% 
9. DEVATHATHAN 20 100% 
10. THANANJAYAN 0 0% 
 
INFERENCE: Abanan,Viyanan and Devathathan affected in all 100% of  patients, 
Koorman  affected in 15% of patients, Pranan affected in 20% of patients, Udhanan 
affected in15% of patients, Samanan affected in 60% patients. 
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PITHAKKUTRAM 
 
S.NO 
 
TYPES OF PITHAM 
 
NO.OF CASES 
 
PERCENTAGE 
     1.        ANALAGAM 12 60% 
     2.        RANJAGAM 16 80% 
     3.        SAATHAGAM 20 100% 
     4.        PRASAGAM 4 20% 
     5.        ALOSAGAM 3 15% 
 
 
INFERENCE 
             Saathagam affected in all the patients 100%, Ranjagam affected in 80% of 
patients, Prasagam affected in 20% and alosagam affected in 15% of patients and 
Analagam affected in 60% of patients. 
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KABHAKUTTRAM\ 
 
S.NO 
 
TYPES OF KABHAM 
 
NO.OF CASES 
 
PERCENTAGE 
    1.         AVALAMBAGAM 4 20% 
    2.         KILETHAGAM 12 60% 
    3.         POTHAGAM 0 0% 
    4.         THARPAGAM 6 30% 
    5.         SANTHIGAM 8 40% 
 
 
INFERENCE 
                        Santhigam affected patients 40% of patients, Kilethagam affected in 
60% of patients,Tharpgam affected in 30% of patients and Avalambagam affected in 
20% of patients. 
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UDALTHATHUKKAL 
 
S.NO 
 
UDAL THATHUKKAL 
 
NO.OF CASES 
 
PERCENTAGE 
     1.            SAARAM 20 100% 
     2.            SENNEER 16 80% 
     3.            OON 0 0% 
     4.            KOZHUPPU 0 0% 
     5.            ENBU 8 40% 
     6.           MOOLAI 0 0% 
     7.           SURONITHAM 20 100% 
 
 
INFERENCE 
                     Saaram and Suronitham affected in all the patients 100%, Senneer 
affected in 80% of patients and Enbu affected in 40% of patients. 
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EN VAGAI THERVUGAL 
NAADI 
 
S.NO 
 
              NAADI 
 
NO.OF CASES 
 
 PERCENTAGE 
 
    1. 
 
      VATHA PITHAM 
 
              7 
 
            35% 
 
    2. 
 
      PITHA VATHAM 
 
              13 
 
            65% 
 
 
INFERENCE 
           65% of patients had Pitha Vatham naadi and 35% of patients had Vadha Pitha 
naadi. 
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MISCELLANEOUS 
 
S.NO 
ENVAGAI 
THERVUGAL 
 
NO.OF CASES/20 
 
PERCENTAGE 
1. NAA 2 10% 
2. NIRAM 2 10% 
3. MOZHI 0 0% 
4. VIZHI 2 10% 
5. MALAM 8 40% 
6. MOOTHIRAM 2 10% 
7. SPARISAM 0 0% 
8. NAADI 20 100% 
 
 
INFERENCE 
                         Vizhi affected in 10% of patients, Naa affected in 10% of patients, 
Niram affected in 10% of patients,  Malam affected in 40% of patients , Moothiram 
affected in 10% of patients and Naadi affected in 100% of patients. 
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NEIKURI 
 
S.NO 
           
           NEER 
 
   NO.OF CASES/20 
 
PERCENTAGE 
 
    1. 
 
         VATHAM 
 
                   7 
 
           35% 
 
    2. 
 
          PITHAM 
 
                   13 
 
           65% 
 
 
INFERENCE 
                  65% of patients had Pitha neer and 35% of patients had Vatha neer. 
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SIGNS AND SYMPTOMS 
 
 
S.NO 
 
 
SIGNS AND SYMPTOMS 
     BEFORE    
TREATMENT 
      AFTER      
TREATMENT 
NO.OF 
CASES 
PERCE
NTAGE 
NO.OF 
CASES 
PERCEN
TAGE 
    1. EXCESSIVE MENSTRUATION 20 100% 1 5% 
    2. PROLONGED MENSTRUATION           20 100% 0 0% 
  3. PRESENCE OF BLOOD CLOTS 20 100% 0 0% 
    4. LOWER ABDOMINAL PAIN 15 75% 1 5% 
    5. LOW BACK ACHE 10 50% 1 5% 
    6. TIREDNESS 20 100% 0 0% 
    7. GIDDINESS 13 65% 1 5% 
    8. HEAD ACHE 3 15% 0 0% 
INFERENCE 
Excessive menstrual bleeding after treatment drawn from 100% to 5%, 
prolonged menstrual bleeding drawn from 100% and presence of blood clots drawn 
from 100% and tiredness  drawn from 100% to 0% and head ache from 15% were 
drawn to 0%, lower abdominal pain from 75% and giddiness from 65% were drawn to 
5%, low back ache from 50% drawn to 5%. 
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NUMBER OF PADS 
BEFORE TREATMENT 
S.NO NO.OF PADS/CYCLE NO.OF CASES/20 PERCENTAGE (%) 
1. ABOVE 20 PADS 2 10 
2. 16-20 PADS 5 25 
3. 11-15 PADS 12 60 
4. BELOW 11 PADS 1 5 
AFTER TREATMENT 
S.NO NO.OF PADS/CYCLE NO.OF CASES/20 PERCENTAGE (%) 
1. ABOVE 20 PADS 1 5 
2. 16-20 PADS 1 5 
3. 11-15 PADS 5 25 
4. BELOW 11 PADS 13 
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NUMBER OF PADS BEFORE AND AFTER TREATMENT 
 
INFERENCE 
After treatment, patients using above 20 pads were drawn from 10% to 5%, 
the patients using 16-20 pads were drawn from 25% to 5%, patients using 11-15 pads 
were drawn from 60% to 25% and the patients using below 11 pads were increased 
from 5% to 65%. 
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HAEMATOLOGICAL OBSERVATION 
BEFORE TREATMENT 
 
S.NO 
 
 HAEMOGLOBIN LEVEL 
 
NO.OF 
CASES/20 
 
 PERCENTAGE 
   1. 10-12 gms 3 15% 
   2. 8-10 gms 13 65% 
   3. 6-8  gms 4 20% 
AFTER TREATMENT 
 
S.NO 
 
HAEMOGLOBIN LEVEL 
 
NO.OF 
CASES/20 
 
 PERCENTAGE 
 1. 10-12 gms 14 70% 
 2. 8-10 gms 5 25% 
 3. 6-8  gms 1 5% 
 
 
INFERENCE  
                    After treatment 6-8 gms of Hb level were noticed in 5% of patients, 8-
10gms of Hb were noticed in 25% of the patients and 10-12 gms of Hb level were 
noticed in 70% of the patients.    
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GRADATION OF RESULTS 
 
 
S.NO 
 
GRADE OF RESULTS 
 
NO.OF CASES/20 
 
PERCENTAGE 
 
1. 
 
GOOD RESPONSE 
 
13 
 
65% 
 
2. 
 
MODERATE RESPONSE 
 
5 
 
25% 
 
3. 
 
 
FAIR RESPONSE 
 
2 
 
10% 
 
 
INFERENCE 
 Good response of treatment was about 65% and moderate response of 
treatment was about 25% and fair response was in 10% of the patients.                   
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NUMBER OF PADS USED BY THE PATIENTS 
BEFORE AND AFTER TREATMENT 
 
S.NO OP.NO PATIENT‘S 
AGE/SEX 
NUMBER OF PADS FOR 
A CYCLE 
 
A CYCLE 
           BT         AT 
1. 5006 36 Yrs/ female 16 10 
2. 8350 30 yrs/ female 22 13 
3. 3489 33 yrs/ female 14 10 
4. 8150 35 yrs/ female 10 7 
5. 7305 35 yrs/ female 15 10 
6. 1191 43 yrs/ female 13 8 
7. 1709 23 yrs/ female 18 11 
8. 1687 40 yrs/ female 14 10 
9. 1686 34 yrs/ female 26 21 
10. 1737 45 yrs/ female 11 8 
11. 1738 21 yrs/ female 22 13 
12. 3457 20 yrs/ female 13 9 
13. 3456 25 yrs/ female 15 10 
14. 5348 20 yrs/ female 15 11 
15. 5346 35 yrs/ female 16 11 
16. 5347 25 yrs/ female 20 12 
17. 5501 40 yrs/female 12 8 
18. 9484 22 yrs/ female 
 
14 10 
19. 6585 50 yrs/ female 13 9 
20. 1179 40 yrs/ female 15 10 
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HAEMOGLOBIN LEVEL 
BEFORE AND AFTER TREATMENT 
 
 
S.NO 
 
OP.NO 
PATIENT‘S 
AGE/SEX 
HAEMOGLOBIN LEVEL IN 
GMS/100ML OF BLOOD 
BT AT 
1. 5006 36 Yrs/ female 8.0 9.1 
2. 8350 30 yrs/ female 6.4 8.3 
3. 3489 33 yrs/ female 8.1 9.5 
4. 8150 35 yrs/ female 9.0 10.2 
5. 7305 35 yrs/ female 9.6 10.5 
6. 1191 43 yrs/ female 10.0 10.8 
7. 1709 23 yrs/ female 9.2 10.5 
8. 1687 40 yrs/ female 9.8 10.5 
9. 1686 34 yrs/ female 7.0 7.9 
10. 1737 45 yrs/ female 10.8 11.4 
11. 1738 21 yrs/ female 9.4 10.6 
12. 3457 20 yrs/ female 9.8 10.5 
13. 3456 25 yrs/ female 9.4 10.2 
14. 5348 20 yrs/ female 9.2 10.2 
15. 5346 35 yrs/ female 10.6 11.2 
16. 5347 25 yrs/ female 8.0 9.4 
17. 5501 40 yrs/female 9.0 10.2 
18. 9484 22 yrs/ female 9.7 10.6 
19. 6585 50 yrs/ female 8.3 9.1 
20. 1179 40 yrs/ female 8.5 10.3 
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BLEEDING  TIME  AND  CLOTTING   TIME 
BEFORE AND AFTER TREATMENT 
S.NO OP.NO PATIENT‘S 
AGE/SEX 
BLEEDING TIME 
Min‘ Sec‖ 
 
 
 
Min‘ Sec‖ 
 
TIME 
 
min‘ sec‖ 
CLOTTING 
TIME 
Min‘ Sec‖ 
 
TIME 
 
min‘ sec‖ 
BT AT BT AT 
1. 5006 36 Yrs/ female 2‘54‖ 2‘20‖ 4‘48‖ 5‘12‖ 
2. 8350 30 yrs/ female 2‘10‖ 1‘22‖ 4‘49‖ 4‘14‖ 
3. 3489 33 yrs/ female 3‘10‖ 2‘54‖ 4‘55‖ 4‘17‖ 
4. 8150 35 yrs/ female 2‘12‖ 2‘10‖ 6‘42‖ 5‘40‖ 
5. 7305 35 yrs/ female 3‘27‖ 2‘44‖ 6‘02‖ 6‘41‖ 
6. 1191 43 yrs/ female 2‘36‖ 1‘10‖ 4‘52‖ 5‘25‖ 
7. 1709 23 yrs/ female 3‘27‖ 2‘10‖ 5‘24‖ 4‘18‖ 
8. 1687 40 yrs/ female 2‘10‖ 1‘10‖ 5‘44‖ 5‘10‖ 
9. 1686 34 yrs/ female 3‘08‖ 2‘58‖ 6‘34‖ 6‘02‖ 
10. 1737 45 yrs/ female 2‘42‖ 2‘40‖ 5‘38‖ 4‘51‖ 
11. 1738 21 yrs/ female 1‘48‖ 1‘18‘ 5‘22‖ 5‘32‖ 
12. 3457 20 yrs/ female 2‘40‖ 1‘08‖ 4‘36‖ 3‘50‖ 
13. 3456 25 yrs/ female 3‘36‖ 2‘10‖ 5‘44‖ 5‘10‖ 
14. 5348 20 yrs/ female 2‘10‖ 1‘54‖ 3‘55‖ 3‘10‖ 
15. 5346 35 yrs/ female 2‘54‖ 2‘06‖ 3‘24‖ 3‘20‘ 
16. 5347 25 yrs/ female 2‘10‖ 1‘46‖ 5‘10‖ 4‘51‖ 
17. 5501 40 yrs/female 3‘09‖ 2‘04‖ 5‘48‖ 5‘16‖ 
18. 9484 22 yrs/ female 
 
2‘24‖ 2‘02‖ 5‘40‖ 4‘39‖ 
19. 6585 50 yrs/ female 2‘54‖ 1‘59‖ 6‘24‖ 5‘15‖ 
20. 1179 40 yrs/ female 2‘55‖ 2‘02‖ 6‘10‘ 5‘39‘ 
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LAB INVESTIGATION REPORT OF PATIENTS 
S 
NO 
OP 
NO BEFORE TREATMENT AFTER TREATMENT BEFORE TREATMENT AFTER TREATMENT 
 
 
 
 
TC DC ESR TC DC ESR SUGAR UREA CHOL SUGAR UREA CHOL 
 
P L E 1/2 1 
 
P L E ½ 1 (mg/dl) (mg/dl) (mg/dl) (mg/dl) (mg/dl) (mg/dl) 
1 5006 8400 64 33 3 7 16 9100 67 32 1 3 9 98 32 160 102 31 169 
2 8350 7800 64 32 4 18 26 8300 64 34 2 6 14 86 31 173 94 32 172 
3 3489 8500 60 36 4 6 15 9450 63 35 2 1 6 80 31 165 92 30 170 
4 8150 8200 50 45 5 26 54 8600 55 42 3 8 20 105 33 196 102 31 190 
5 7305 7700 65 32 3 10 22 8100 64 35 1 4 9 96 27 166 100 29 168 
6 1191 7400 50 45 5 15 40 7800 60 38 2 4 18 100 29 167 105 28 172 
7 1709 9000 62 32 4 12 22 9200 62 36 2 3 9 110 31 160 108 30 156 
8 1687 8300 61 34 5 26 50 8950 65 34 1 9 18 82 27 178 90 30 180 
9 1686 8600 68 27 5 12 20 9300 66 33 1 2 8 93 32 189 99 31 182 
10 1737 6300 75 21 4 2 7 7500 69 31 0 2 7 189 35 158 105 33 160 
11 1738 8300 62 35 3 2 5 8650 63 36 1 0 2 110 31 143 96 32 150 
12 3457 9600 68 29 3 16 30 9950 66 32 1 2 14 108 31 175 102 29 172 
13 3456 7000 50 45 5 2 4 7000 54 44 2 1 2 120 34 158 124 33 166 
14 5348 8900 64 31 5 18 34 9100 63 35 2 6 15 88 32 187 102 30 180 
15 5346 8600 57 39 4 3 10 9200 59 38 3 1 4 98 28 173 96 32 188 
16 5347 8700 62 35 3 12 20 8900 63 36 1 9 18 96 36 160 98 34 156 
17 5501 8900 61 34 5 4 12 9400 64 35 1 2 6 99 24 156 105 23 160 
18 9484 8600 64 32 4 8 26 9600 65 34 1 2 16 90 32 169 98 30 172 
19 6585 7400 56 49 5 18 40 8100 59 37 4 8 15 82 34 144 90 31 152 
20 1179 7900 68 28 4 2 6 8300 69 29 2 5 12 104 33 150 102 34 145 
TC: TOTAL COUNT        DC: DIFFERENTIAL COUNT                         ESR: ERYTHROCYTE SEDIMENTATION RATE 
A:ALBUMIN                                                              S:SUGAR                                                            D:DEPOSITS
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DISCUSSION 
                    PITHA  PERUMBADU ROGAM   which has been compared with the 
modern clinical entity MENORRHAGIA. Menstrual disorders are the second most 
common gynaecological condition to be referred to hospitals. Among the menstrual 
disorders MENORRHAGIA is the most common gynaecological disorder in the 
reproductive system of women. Around 30% of women reports heavy menstrual 
bleeding. 
                      Most common cause of Menorrhagia are Dysfunctional uterine 
bleeding, Fibroid uterus, endometrial polyp, poly cystic ovarian disease, 
Adenomyosis and chronic tubo-ovarian mass. Long duration of menstrual blood flow, 
passage of blood clots, use of increased number of sanitary pads, pallor and low level 
of haemoglobin give an idea about the correct diagnosis and magnitude of  
menorrhagia. 
 
                       Menorrhagia interfere with a Women’s physical, emotional, Social and 
mental quality of life. It can occur alone or in combination with other symptoms. It is 
related to increased limitations in physical activities and limitations in social and 
leisure activities.                       
                       The definitive treatment is appropriate to the cause for menorrhagia. 
Hence with the help of the trial medicine from the Siddha system of medicine, results 
and observations are noted for this study. 
 
                       20 patients with PITHA PERUMBADU ROGAM were selected. The 
patients were examined  based on Siddha and as well as modern aspects. All the 
necessary investigations were made for all patients during the study. All the patients 
were administered with the trial medicine. 
                        The clinical improvement of the patients were completely observed 
and efficacy of the trial medicine have been studied . Results obtained were discussed 
below for better conclusion. 
                 Trial drug administered was  Naaval nei – 5gm thrice a day after food for 
one Mandalam (48 days). 
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DRUG AUTHENTICATION 
The required raw drugs are obtained  from a well reputed indigenous raw drug 
shop. The raw drugs taken for study was authenticated  by the  Botanist, Govt. Siddha  
Medical College, Chennai 600106. 
PRE CLINICAL STUDIES 
Physiochemical  analysis 
The Loss on drying (at 105° C) was 31.378% 
The  total  ash  value  of  Naaval Nei  was 4.15% 
The  water  soluble ash value was 2.205% 
The  acid  insoluble ash  value was 0.615 % 
Water  soluble  extractive  value was 15.06 % 
Alcohol  soluble  extractive  value was 2.165% 
 Acid value was 23.0 
 Saponification value was 244 
 Iodine value was 28.0 
 Peroxide value was 0.2006 
 pH value (10%) was 6.51 
TOXICOLOGICAL STUDY 
Acute toxicity study 
Acute toxicity study of the study drug Navaal Nei was carried out as per 
OECD guideline (Organization for Economic Co-operation and Development) 
Guideline-423. The experimental protocol was approved by The Institutional Animal 
Ethics Committee of Sathyabama University, Chennai, Tamil Nadu, India. IAEC 
reference number : SU/CLATR/IAEC/IV/017/2016. The study was conducted with 
single oral dose administration of Navaal Nei.  In acute toxicity test the NAAVAL 
NEI was found to be non toxic at the dose level of 2000mg/kg body weight. 
Sub-acute toxicity study 
 Sub-acute toxicity study was carried out as per OECD guidelines – 407. At the 
end of the studies the animals were sacrificed and the haematological parameters, 
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biochemical parameters, urine parameters and the histopathology of the vital organs 
like liver, heart, spleen and kidney were carried out. The study results show that the 
trial drug was safe, and did not produced any toxic effects. 
Pharmacological Evaluation 
The experimental protocol was approved by The Institutional Animal Ethics 
Committee of Sathyabama University, Chennai, Tamil Nadu, India. IAEC: 
SU/CLATR/IEAC/VII/049/2016 . Pharmacological Evaluation of styptic activity of 
Naaval nei on Aspirin induced bleeding time prolongation in rats .The result shows 
that the trial drug NAAVAL NEI has styptic activity. 
BIOCHEMICAL ANALYSIS  
In Naaval nei, basic radicals like iron, calcium and reducing sugar were 
present . 
CLINICAL STUDIES 
Study design 
A clinical trial on PITHA PERUMBADU ROGAM was conducted at the OPD 
section of POST GRADUATE, POTHU MARUTHUVAM DEPARTMENT attached 
to ARIGNAR ANNA GOVERNMENT  HOSPITAL OF INDIAN MEDICINE, 
Chennai-106, during the period 2015-2017. 
     
 The study was approved by Institutional Ethics Committe (IEC) and the 
approved number is GSMC-CH-ME-4/2015/005. The stydy was registered in Clinical 
Trials Registry – India (CTRI) and the reference no is CTRI/2017/05/008615.  
 
Sample size 
  
20 patients in the age group 15-50 years. 
Age distribution  
Women with the reproductive age 15-50 were affected with the disease. The 
incidence  is more in the age of  15-25 years about  35%, in the age group of 26-35 
years about 30%, in the age group of 36-45 years about 30%  46-50 years about 5%. 
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Occupational reference 
 60% of patients were house wife, 30% of patients were working women and 
10% of  patients were students. 
Marital status 
   75% of patients were married and 25% of patients were unmarried. 
Socio-economic status 
    45% of patients were from middle income group, 25% of patients were upper 
income group and 30% of patients were from low income group. 
Food habits 
   70% of patients have mixed diet habit and 30% of patients were vegetarians. 
Distribution of Landscapes (Thinai) 
 As the trial was conducted in Chennai which is Neithal nilam, most of 
patients about 80% were from Neithal Nilam and  20% of patients were from Marutha 
Nilam. 
Seasonal Reference 
  25% of patients were reported in Kaarkaalam , 10% of patients were reported 
in  Elavenil kaalam and  Muthuvenil kaalam, 15% of patients were reported in 
munpanikaalam and 40% of patients were reported in pinpanikaalam.   
Mukkutram  
In Perumbadu, the clinical condition is due to the imbalance of PITHAM. 
Pitham is deranged primarily and later it deranges vatha and the derangement of 
Pitha-vatha leads to the derangement of Abanaan which in turn cause the disease. The 
pathogenesis of the disease depends upon the affected Pitha and Vatha. 
Vatham 
Abaanan (100%), Pranan (20%),Udhanan (15%), Viyanan (100%), Koorman (15%), 
Samanan (60%), and Devathathan (100)% were affected. 
 Affected Abaanan results in causing excessive and prolonged menstruation 
bleeding. 
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 Affected Pranan results in causing dyspnoea and breathlessness due to low Hb 
level. 
 Affected Viyanan results in causing lower abdominal pain and low back ache 
headache and body pain. 
 Affected Udhanan results in producing  nausea, vomiting and cough. 
 Affected Koorman results in causing visual disturbances.. 
 Affected Samaanan and Devathathan results in producing loss of appetite or 
indigestion and tiredness respectively. 
Pitham 
Saathagam (100%), Ranjagam (80%), Alosagam (15%), Praasagam (20%) and 
Analagam (60%) were affected. 
 
 Affected Saathaga  Pitham results in causing general malaise, tiredness and 
giddiness. 
 Affected Ranjaga pitham results in low Hb level. 
 Affected Praasagam results in pallor of skin  due to very low level of 
haemoglobin.  
 Affected Aalosaga pitham results in producing dimness of vision. 
 Affected Analaga Pitham results in causing loss of appetite respectively. 
Kabham 
Avalambagam (20%), Kilethagam ( 60%), Tharpagam (30%), Santhigam (40%) were 
affected. 
 Affected Avalambagam results in producing low Hb levels. 
 Affected Santhigam results in producing low back ache. 
 Affected Kilethagam results in causing loss of appetite. 
 Affected Tharpagam results in producing burning sensation. 
Ezhu Udal Thathukkal  
Saaram (100%), Senneer (80%), Enbu(40%), Suronitham (100%) were affected. 
 Affected Saaram results in causing loss of appetite and tiredness. 
 Affected Senneer results in causing decreased level of haemoglobin in blood. 
 Affected Enbu results in causing  Low back ache. 
 Affected Suronitham results due to presence of excessive menstruation. 
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Envagai Thervugal  
Among 20 patients, 
Naa (10%), Niram (10%), Vizhi (10%), Malam (40%),Moothiram (10%) and 
Naadi (100%) were affected. 
Pitha vatha naadi (65%) and  Vatha pitha naadi (35%). 
 Affcted Naa results in paleness of tongue. 
 Affected Niram results in  pallor of the skin due to low Hb level. 
 Affected Vizhi results in paleness of lower eyelids due to low level of 
haemoglobin. 
 Affected Malam was due to constipation. 
 Affected Moothiram was due to burning micturation. 
 Naadi 
Pitha vatha naadi (65%) and Vatha Pitha naadi (35%) were noticed.  
Pitha vatha naadi and Vatha Pitha naadi was due to derangement of Pitham 
and Vatham. 
Neikuri 
Pitha neer (65%) and vatha neer (35%) was observed. 
Haematological findings 
              Blood routines were sampled. 
                It was observed that 100% of patients show elevation of haemoglobin level 
in blood. 
               Bleeding time and clotting time investigation was taken for affordable 
patients to exclude blood disorders. 
Special investigation 
                 USG Abdomen and pelvis was taken before the treatment. 
                 The impression found on USG pelvis was Fibroid uterus, poly cystic 
ovarian disease and bulky uterus in most of the cases. 
                  After confirming the results, the patients were given the trial medicines 
and instructed to follow the diet and other restriction based on siddha system. 
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Mode of action of the Trial drug  
Based on taste (Suvai) 
                      In the trial drug Naaval Nei - most of the incredients included in this 
trial drug were thuvarppu, kaippu  and inippu suvai. 
Basically astringent taste has the characteristic action of: 
 Treats the derangement of pitham 
 Causes vaso constriction 
 Decreases the secretions 
 Purifies the blood 
 Cures the ulcer  
Basically bitter taste has the following characteristics: 
 Treats the derangement of Pitham. 
 Cures loss of appetite. 
 Removes toxins from body. 
Basically sweetness taste has the following characteristics : 
 Treats the derangement of Pitham. 
 Nourishes the body 
By this, the trial drug  Naaval Nei treats the derangement of pitha which is the 
main cause of disease and also controls bleeding by vaso constriction. Hence it acts as 
an effective drug in Pitha Perumbadu Rogam and considered to be Ethirurai 
maruthuvam. 
Based on Nature (Veeriyam) 
                           The trial drug   Naaval Nei  is of Thatppam  nature as the ingredients 
in this has thatppa nature. 
Clinical Manifestation 
Among the total 20 patients all were improved both subjectively and 
objectively. 
Clinical symptoms before and after treatment were noted. To obtain 
the prognosis of each clinical symptoms the following formulae was used. 
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     Number of cases after Treatment 
_________________________________     × 100 
                             
     Number of cases before Treatment 
 
Thus the clinical trial study showed  significant clinical  improvement in 
certain clinical manifestations of Pitha Perumbadu Rogam such as excessive 
menstruation (95%), Prolonged menstruation (100%), Presence of blood clots 
(100%) Lower abdominal pain (70%), Low back ache (45%), Tiredness (100%) and 
Giddiness (60%), Head ache (15%) were relieved. 
Haemoglobin level of blood is elevated in all the patients. Since, most of the 
ingredients present in the trial drug as haematinic activity. 
Biostatistics 
Since the p value is significant in all signs and symptoms. So there is 
significant reducing of signs & symptoms among the patients for the treatment of 
Pitha Perumbadu (Menorrhagia). Statistical analysis of  clinical study was done 
from the subjective and objective  parameters (Number of pads, Bleeding time and 
Clotting time) observed before and after treatment. They showed highly 
significant. Since the P value is highly significant (< 0.001),  So the treatment was 
significantly improving the Hb level among the patients for the treatment of Pitha 
Perumbadu. Hence it is concluded that the treatment was effective and significant. 
Grading of results  
Out of 20 patients, 13 cases (65%) shows good result, 5 cases (25%) shows 
moderate result, 2cases (10%) shows fair result . 
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SUMMARY 
 The clinical study on PITHA PERUMBADU ROGAM was carried out in Post 
graduate department of Maruthuvam, Government Siddha  Medical College, Aringar 
Anna Government Hospital, Chennai – 106 during the period of 2015 - 2017. 
 A total of  20 patients were treated in the Outpatient department. The clinical 
and pathological assessment was carried out on the basis of Siddha and Modern 
aspects. 
 All the patients were treated with NAAVAL NEI (5 gm TDS ). The duration 
of the treatment was fixed as ONE MANDALAM (48 DAYS).   
 The comparatively larger incidence of Pitha perumbadu was found to 
be in 15-25 years of age. 
 The prevalence of the disease was high among Middle class 
populations 45% followed  by  Lower class 30% and High class 
population 25%. 
 Out of 20 patients, 2 patient (10%) were a student, 6 patients (30%) 
were working women,12 patients (60%) were house wife. 
 In case of diet, 70% patients consume Mixed  diet. 
 From selected 20 patients, 5 patients (25%) comes under Kaarkaalam, 
3 patients (15%) comes under Munpani, 2 patients ( 10%) comes under 
Elavenil, 2 patients (10%) comes under Mudhuvenil kaalam and 8 
patients (40%) comes under Pinpanikaalam. 
 Out of 20 patients, 80% comes under Neithal category. 
 In mukkutram  aspect - In Vatham 
Abanan (100%), Praanan (20%), Viyanan (100%), Udhanan (15%),  
Koorman (15%), Samanan (60%), and  Devathathan (100)% were affected. 
 In Pitham 
Sathagam (100%), Ranjagam (80%), Alosagam (15%), Praasagam (20%) and 
Analagam (60%) were affected. 
 In Kabham 
 Avalambagam (20%), Kilethagam (60%), Tharpgam (30%),  Santhigam 
(40%) were affected. 
 Among Ezhu Udal Thathukkal, Saaram (100%), Senneer (80%), Enbu 
(40%), Suronitham (100%) were affected. 
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 Among Envagai Thervugal Naa (10%), Niram (10%), Vizhi (10%), 
Malam (40%) Moothiram (10%) and Naadi (100%)  were affected. 
 Naadi showed Pitha vatha naadi (65%) and  Vatha pitha naadi (35%). 
 In neikuri examination Pitha neer (65%) and vatha neer (35%) were 
seen. 
 
The ingredients of trial medicines were found to have the properties of  
reducing the symptoms of  PITHA PERUMBADU ROGAM. In Naaval Nei, 
basic radicals like  iron, calcium and reducing sugar were present.  
 
The Toxicological studies of the trial medicine reveals no toxicity. 
 
The  Pharmacological studies of the trial medicine shows styptic activity. 
 
The Bio statistical report of the clinical trial shows significant P value and thus 
concluded that, the treatment is effective and significant. 
 
Among 20 patients, 65%  of cases showed good result and 25% of cases 
showed moderate result and 10%  of cases showed fair result in PITHA 
PERUMBADU ROGAM (MENORRHAGIA).  
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CONCLUSION 
 Pitha Perumbadu is primarily due to the derangement of Pitha kutram. 
The ingredients of  the medicine Naaval nei  have the properties of 
neutralizing the deranged kutram. 
 From the preclinical toxicity studies, the medicine Naaval nei  
revealed no toxicity and proved to be safe. 
 From the preclinical pharmacological studies, it is evident that the  
medicine Naaval nei have Styptic activity. 
 No adverse effects was reported during the course of the treatment. 
 The medicine Naaval nei which gives a maximum relief from the 
considerable symptoms of Menorrhagia such as excessive 
menstruation, prolonged menstruation, presence of blood clots, lower 
abdominal pain and low back ache. 
 The ingredients of the trial drug is easily available. 
 The trial medicine is economical and  palatable. 
Therefore I conclude that, the medicine Naaval nei can give a 
better solution for Pitha Perumbadu.  
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Project Report on Toxicity Profiling of Naval Nei 
Name    : Dr. S. Jayapriya 
IAEC    : SU/CLATR/IAEC/017/2016 
Name of the  Formulation : Naaval  Nei 
Abbreviation   : NN    
ACUTE TOXICITY STUDY 
Acute toxicity study of the study drug Naval Nei was carried out as per OECD 
guideline (Organization for Economic Co-operation and Development) Guideline-
423. 
Animal 
Healthy adult Wistar albino rat weighing between 170-200 g were used for the 
study.  The animals were housed in poly propylene cages and were kept in well 
ventilated with 100% fresh air by air handling unit (AHU). A 12 light / dark cycle 
were maintained .Room temperature was maintained between 22 + 2
0 
C
 
and relative 
humidity 50–65%. They were provided with food (Sai feeds, Bangalore, India) and 
water ad libitum. All the animals were acclimatized to the laboratory for 7 days prior 
to the start of the study. 
The experimental protocol was approved by The Institutional Animal Ethics 
Committee of Sathyabama University, Chennai, Tamil Nadu, India. 
Acute toxicity Study 
Acute toxicity study will be carried out in accordance with OECD guideline 423 
(74)
. 
The animals were fasted overnight with free access to water. The study was conducted with 
single oral dose administration of Naval Nei.  
IAEC SU/CLATR/IAEC/IV/017/2016 
Animal Grouping 
One group consist of 6 female rats were used for this study. The dose utilized 
for evaluation of acute toxicity study is about 2000 mg/kg higher than that of the 
therapeutic dose.  
Dose Equivalent = 1ml is equivalent to 1.0972 gm 
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Animal Grouping 
GROUP I : Animals received Test drug 2000 mg/kg (p.o)  
The animals were fasted overnight (12- 16 hrs) with free access to water. The 
study was conducted with single oral administration of study drug Naval Nei 
2000mg/kg equivalent to 0.5ml(p.o). The animals were observed continuously for 
first 72 h and then 14 days for emerging signs of behavioral changes, body weight 
changes and for mortality. 
Occurrence of toxicity in animals were observed continuously for the first 4 to 
24 h and observed periodically for the next 14 days.  Observation includes the change 
in skin, fur, eyes and mucus membrane. Appearance of C.N.S,C.V.S and A.N.S related 
toxicity such as tremors, convulsions, sedation, steric behavior, respiratory distress, 
cardiovascular collapse, response to sensory stimuli, salivation, diarrhea, lethargy, 
sleep, coma and mortality were observed with special attention.   
Body weight was recorded periodically. At the end of the experiment all animals 
were subjected for gross necropsy and observed for pathological changes. 
SUB-ACUTE TOXICITY STUDY 
Sub-acute toxicity study was carried out as per OECD guidelines Guideline-
407 
(75)
. 
Animals 
Healthy adult Wistar albino rat weighing between 170-200 g were used for the 
study.  The animals were housed in poly propylene cages and were kept in well 
ventilated with 100% fresh air by air handling unit (AHU). A 12 light / dark cycle 
were maintained .Room temperature was maintained between 22 + 2
o 
C
 
and relative 
humidity 50–65%. They were provided with food (Sai feeds, Bangalore, India) and 
water ad libitum. All the animals were acclimatized to the laboratory for 7 days prior 
to the start of the study. 
The experimental protocol was approved by The Institutional Animal Ethics 
Committee of Sathyabama University, Chennai, Tamil Nadu, India. 
IAEC SU/CLATR/IAEC/IV/017/2016 
Animal Grouping 
Animals were divided into three groups of 06 animals each consist of 3 male 
and 3 female rats. 
GROUP I : Animals received saline 5 ml/kg b.w (p.o)             
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GROUP II : Animals received low dose of test drug 200 mg/kg (p.o) 
GROUP III : Animals received high dose of test drug 400 mg/kg (p.o) 
The animals were randomly divided into control group and drug treated groups for 
two different doses viz. low dose (200 mg/kg b.w) equivalent to 0.05 ml and high dose (400 
mg/kg b.w) equivalent to 0.1 ml,p.o per rat. 
The animals were administrated with the study drug once daily for 28 days. The 
animals in group I (control group) received normal saline 5 ml/kg b.w. The animals in group 
II received low dose of Naval Nei 200 mg/kg b.w (p.o) and group III received high dose of 
Naval Nei 400 mg/kg b.w (p.o). 
The rats were weighed periodically and observed for signs of toxicity pertains to 
C.N.S, C.V.S, A.N.S including behavioral changes, food - water intake and morphological 
changes. At the end of 28
th
 day, the animals were fasted for overnight with free access to 
water. On 29
th
 day the animals were sacrificed with excess anesthesia. Blood samples were 
collected from aorta and stored in EDTA (ethylenediamine –tetra actate) for Hematological 
analysis and for serum generation for biochemical analysis. 
The vital organs including heart, brain, lungs, spleen, kidneys, liver, stomach, 
testes, and ovary were harvested and carefully examined for gross lesions. The organs 
were preserved in 10% formalin for histopathological assessment and interpretation. 
Hematological analysis 
Blood samples were analyzed using established procedures and automated 
Bayer Hematology analyzer. Parameters evaluated include Packed Cell Volume 
(PCV), Red Blood Cells (RBC) count, White blood cell count (WBC), Platelet Count, 
Hemoglobin (Hb), Mean cell Haemoglobin Concentration (MCHC), Mean Red Cell 
Volume (MCV), Mean Cell Hemoglobin (MCH), Mean platelet volume (MPV), 
Neutrophils, Eosinophil’s, Basophils, Lymphocytes and Monocytes.  
Biochemical analysis 
(76)
 
Serum samples were analyzed for High Density Lipoprotein (HDL), Low 
density Lipoprotein (LDL), Very low density Lipoprotein (VLDL) , Triglycerides 
(TGL), Total Cholesterol , Blood urea nitrogen (BUN), Creatinine, Albumin, Total 
Protein, Glucose, Uric acid, Aspartate Transaminase (AST), Alanine amino 
Transaminase (ALT) and Alkaline   
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Acute Toxicity Study 
Analysis Group I 
Consistency Soft -Pasty 
Shape Oblong 
Colour Greenish 
Mucous Shedding Absence 
Blood Cells Absent 
Signs of Infection None Observed 
 
 
Sub-Acute Toxicity Study 
Analysis Group I Group II Group III 
Consistency Soft Soft Soft -Pasty 
Shape Oblong Pointed Head Pointed Head 
Colour Brownish green Greenish Greenish 
Mucous Shedding Absence Absence Absence 
Blood Cells Absent Absent Absent 
Signs of Infection None Observed None Observed None Observed 
RESULTS 
Assessment of clinical signs in rats treated with Naval Nei on Acute toxicity study 
Parameter Group I 
Clinical Signs Parameters 
for the duration of 14 
days 
Test Drug 
2000mg/ Kg    
Number of animals 
observed 6 Female  
Lacrimation Absence 
Salivation Absence 
Animal appearance Normal 
Tonic Movement Absence 
Clonic Movement Absence 
Laxative action Mild 
Touch Response Normal 
Response to Sound 
Normal 
Response 
Response to Light 
Normal 
Response 
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Mobility 
Normal 
Response 
Respiratory Distress Nil 
Skin Color Normal 
Stereotype behavior Absence 
Piloerection Absence 
Limb Paralysis Absence 
Posture Normal 
Open field behavior Normal 
Gait Balancing Normal 
Freezing Behaviour Absent 
Sings of Stress and 
Anxiety None Observed 
Muscular coordination Normal 
Muscle grip Normal 
Sedation Absence 
Social Behavior Normal 
Urine Analysis 
No 
Abnormality 
Urine Colour 
Yellowish 
Orange 
Urine pH 7 
Urine -
Glucose                         Absence 
Urine -
Ketones                        Absence 
Urine- 
Bilirubin                         Absence 
Urine-Blood  Cells       Negative 
Urine - Pus cells Negative 
Mortality Nil 
 
Quantitative data on the body weight of rats treated with Naval Nei in Acute 
toxicity study 
Group I 
Before Treatment Weight in 
Gms 
After Treatment Weight in 
Gms 
Mean 
181.8 187.2 
Std. Deviation 
6.94 7.36 
Std. Error 
2.833 3.005 
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Values are mean ± S.D (n = 6 per group). Control and treatment group were compared 
statistically using one way ANOVA followed by Dunnett’s test. 
Assessment of clinical signs in rats treated with Naval Nei on Sub-Acute toxicity 
study 
Parameter Group I Group II Group III 
Clinical Signs Parameters 
for the duration of 28 
days Control 
Test Drug 
200mg/ Kg    
Test Drug 
400mg/ Kg    
Number of animals 
observed 
3 Male and 3 
Female 
3 Male and 
3 Female 
3 Male and 
3 Female 
Lacrimation Absence Absence Absence 
Salivation Absence Absence Absence 
Animal appearance Normal Normal Normal 
Tonic Movement Absence Absence Absence 
Clonic Movement Absence Absence Absence 
Laxative action Absence Absence Moderate 
Touch Response Normal Normal Normal 
Response to Sound 
Normal 
Response 
Normal 
Response 
Normal 
Response 
Response to Light 
Normal 
Response 
Normal 
Response 
Normal 
Response 
Mobility Normal Normal Normal 
Respiratory Distress Nil Nil Nil 
Skin Color Normal Normal Normal 
Stereotype behavior Absence Absence Absence 
Piloerection Absence Absence Absence 
Limb Paralysis Absence Absence Absence 
Posture Normal Normal Normal 
Open field behavior Normal Normal Normal 
Gait Balancing Normal Normal Normal 
Freezing Behaviour Absent Absent Absent 
Sings of Stress and 
Anxiety 
None 
Observed 
None 
Observed 
None 
Observed 
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Muscular coordination Normal Normal Normal 
Muscle grip Normal Normal Normal 
Sedation Absence Absence Absence 
Social Behavior Normal Normal Normal 
Urine Analysis 
No 
Abnormality 
No 
Abnormality 
No 
Abnormality 
Urine Colour Yellowish Yellowish Yellowish 
Urine pH 7 7 7 
Urine -
Glucose                         Absence Absence Absence 
Urine -
Ketones                        Absence Absence Absence 
Urine- 
Bilirubin                         Absence Absence Absence 
Urine-Blood  Cells       Negative Negative Negative 
Urine - Pus cells Negative Negative Negative 
Mortality Nil Nil Nil 
 
Effect of Naval Nei on Body weight of Rats in Sub-acute toxicity study 
Group I 
Before Treatment Weight in 
Gms 
After Treatment Weight in 
Gms 
Mean 
187.3 198.7 
Std. Deviation 
5.645 6.408 
Std. Error 
2.305 2.616 
Group II 
Before Treatment Weight in 
Gms 
After Treatment Weight in 
Gms 
Mean 
184.5 194.2 
Std. Deviation 
7.868 10.07 
Std. Error 
3.212 4.11 
Group III 
Before Treatment Wt in 
Gms 
After Treatment Weight in 
Gms 
Mean 
188.2 200.8 
Std. Deviation 
4.07 4.215 
Std. Error 
1.662 1.721 
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Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control and 
treatment groups were compared statistically using one way ANOVA followed by 
Dunnett’s test. 
Quantitative data on the food and water intake of rats treated with Naval Nei for 
28 days in Sub-acute toxicity study 
Group I Food intake Water intake 
Mean 19.25 41.25 
Std. Deviation 3.072 1.371 
Std. Error 1.536 0.6855 
Group II Food intake Water intake 
Mean 18.5 26.5 
Std. Deviation 1.895 1.401 
Std. Error 0.9477 0.7005 
Group III Food intake Water intake 
Mean 18.5 31 
Std. Deviation 2.589 0.7201 
Std. Error 1.295 0.36 
 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control and 
treatment groups were compared statistically using one way ANOVA followed by 
Dunnett’s test. 
Effect of Naval Nei on Haematology profile of rats in sub-acute toxicity study. 
Group I 
 WBC 
count 
(×10
3
 
µl) 
RBC 
(×10 
6
 
µl) 
PLT 
(×10 
3
 
µl) 
MCV     
(fl) 
MCH    
(pg) 
MCHC 
(g/dl) 
HGB 
(g/dl) 
Mean 13.5 7.217 684.3 63.22 19.37 31.47 11.88 
Std. 
Deviation 1.536 1.559 90.86 4.269 3.838 2.083 2.109 
Std. Error 0.6272 0.6364 37.09 1.743 1.567 0.8504 0.8612 
Group II 
 WBC 
count 
(×10
3
 
µl) 
RBC 
(×10 
6
 
µl) 
PLT 
(×10 
3
 
µl) 
MCV     
(fl) 
MCH    
(pg) 
MCHC 
(g/dl) 
HGB 
(g/dl) 
Mean 11.2 5.9 693.2 59.77 21.67 31.57 11.65 
Std. 
Deviation 1.427 0.7403 361.4 3.869 1.878 2.055 1.3 
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Std. Error 0.5825 0.3022 147.5 1.579 0.7667 0.8389 0.5309 
Group 
III 
 WBC 
count 
(×10
3
 
µl) 
RBC 
(×10 
6
 
µl) 
PLT 
(×10 
3
 
µl) 
MCV     
(fl) 
MCH    
(pg) 
MCHC 
(g/dl) 
HGB 
(g/dl) 
Mean 10.45 7.15 874 60.97 18.1 32.92 11.63 
Std. 
Deviation 2.344 0.9354 139.2 7.68 2.445 1.266 1.407 
Std. Error 0.9568 0.3819 56.83 3.135 0.9983 0.5167 0.5743 
 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control and 
treatment groups were compared statistically using one way ANOVA followed by 
Dunnett’s test. 
Effect of Naval Nei on Haematology profile of rats in sub-acute toxicity study. 
Group I 
Lymph        
(%) 
Mon            
(%) 
Neutrophils   
(X 
10
3
/mm
3
) 
Eosinophils 
(%) 
Basophils 
(%) 
MPV 
(fl) 
Mean 70.74 2.1 2.533 1.3 0.5 6.267 
Std. Deviation 6.62 0.7874 1.001 0.2828 0.5477 1.283 
Std. Error 2.702 0.3215 0.4088 0.1155 0.2236 0.5239 
Group II 
Lymph        
(%) 
Mon            
(%) 
Neutrophils     
(X 
10
3
/mm
3
) 
Eosinophils 
(%) 
Basophils 
(%) 
MPV 
(fl) 
Mean 70.15 4.083 1.633 1.5 0.3333 5.617 
Std. Deviation 7.654 1.379 0.4803 0.2449 0.5164 1.43 
Std. Error 3.125 0.563 0.1961 0.1 0.2108 0.5839 
Group III 
Lymph        
(%) 
Mon            
(%) 
Neutrophils     
(X 
10
3
/mm
3
) 
Eosinophils 
(%) 
Basophils 
(%) 
MPV 
(fl) 
Mean 66.12 2.7 2.833 1.55 0.3333 5.233 
Std. Deviation 4.221 1.352 0.5785 0.2429 0.5164 0.9309 
Std. Error 1.723 0.552 0.2362 0.09916 0.2108 0.3801 
 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control and 
treatment groups were compared statistically using one way ANOVA followed by 
Dunnett’s test. 
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Effect of Naval Nei on Serum Bio-chemistry profile of rats in sub-acute toxicity 
study 
Group I 
Bloo
d 
sugar 
® 
(mg/
dl) 
BUN 
(mg/dl) 
 
Seru
m 
creati
nine 
(mg/d
l) 
Serum 
total 
cholest
erol 
(mg/dl
) 
Serum 
triglyce
rides 
level 
(mg/dl) 
Serum 
HDL 
cholest
erol 
(mg/dl
) 
Serum 
LDL 
cholest
erol 
(mg/dl
) 
Serum 
VLDL 
cholest
erol 
(mg/dl
) 
Mean 86.17 11.17 
0.616
7 117.2 80.67 68.67 29.67 16.82 
Std. 
Deviatio
n 8.931 3.251 
0.299
4 16.98 11.93 12.45 17.75 1.707 
Std. 
Error 3.646 1.327 
0.122
2 6.93 4.869 5.084 7.246 0.6969 
Group 
II 
Bloo
d 
sugar 
®(mg
/dl) 
BUN(m
g/dl) 
 
Seru
m 
creati
nine 
(mg/d
l) 
Serum 
total 
cholest
erol 
(mg/dl
) 
Serum 
triglyce
rides 
level 
(mg/dl) 
Serum 
HDL 
cholest
erol 
(mg/dl
) 
Serum 
LDL 
cholest
erol 
(mg/dl
) 
Serum 
VLDL 
cholest
erol 
(mg/dl
) 
Mean 85.67 16.67 0.7 100.3 73.67 51.33 33.83 
14.55 
Std. 
Deviatio
n 8.869 3.983 
0.154
9 12.94 11.79 4.926 10.61 
2.192 
Std. 
Error 3.621 1.626 
0.063
25 5.283 4.814 2.011 4.331 
0.8951 
Group 
III 
Bloo
d 
sugar 
® 
(mg/
dl) 
BUN 
(mg/dl) 
 
Seru
m 
creati
nine 
(mg/d
l) 
Serum 
total 
cholest
erol 
(mg/dl
) 
Serum 
triglyce
rides 
level 
(mg/dl) 
Serum 
HDL 
cholest
erol 
(mg/dl
) 
Serum 
LDL 
cholest
erol 
(mg/dl
) 
Serum 
VLDL 
cholest
erol 
(mg/dl
) 
Mean 86.5 13.67 
0.833
3 112.3 77 66.33 28.17 18.07 
Std. 
Deviatio
n 11.64 2.338 
0.186
2 17.29 12.93 8.454 9.806 2.936 
Std. 
Error 4.752 0.9545 
0.076
01 7.06 5.279 3.451 4.003 1.199 
 
113 
 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control and 
treatment groups were compared statistically using one way ANOVA followed by 
Dunnett’s test. 
Effect of Naval Nei on Serum Bio-chemistry profile of rats in sub-acute toxicity 
study 
Group I 
Serum 
total 
protein 
(g/dl) 
Serum 
albumin 
(g/dl) 
(AST)  
(IU/ml) 
(ALT) 
(IU/L) 
(ALP) 
(IU/L) 
Mean 4.917 3.717 99.5 32.83 247 
Std. 
Deviation 2.043 1.08 22.51 10.57 20.91 
Std. Error 0.834 0.4408 9.19 4.316 8.536 
Group II 
Serum 
total 
protein 
(g/dl) 
Serum 
albumin 
(g/dl) 
(AST)  
(IU/ml) 
(ALT) 
(IU/L) 
(ALP) 
(IU/L) 
Mean 4.517 3.433 93 34.67 216.7 
Std. 
Deviation 1.021 0.575 24.1 8.618 66.68 
Std. Error 0.4167 0.2348 9.839 3.518 27.22 
Group III 
Serum 
total 
protein 
(g/dl) 
Serum 
albumin 
(g/dl) 
(AST)  
(IU/ml) 
(ALT) 
(IU/L) 
(ALP) 
(IU/L) 
Mean 4.583 3.4 97 24.33 172.2 
Std. 
Deviation 1.304 0.7321 26.41 6.121 34.7 
Std. Error 0.5326 0.2989 10.78 2.499 14.17 
 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control and 
treatment groups were compared statistically using one way ANOVA followed by 
Dunnett’s test. 
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Quantitative data on absolute organ weight of rats treated with Naval Nei for 28 
days in Sub-acute toxicity study. 
Group I 
HEA
RT 
(gms
) 
 
LIV
ER 
(gms
) 
KIDN
EYS 
(gms) 
SPLE
EN 
(gms) 
BRA
IN   
(gms
) 
LUN
G    
(gms
) 
STOM
ACH               
(gms) 
TES
TES 
(gms) 
UTE
RUS 
& 
OVA
RY 
(gms) 
Mean 
0.541
7 6.62 1.507 0.4 
1.66
7 
1.63
3 1.183 2.533 1.133 
Std. 
Deviatio
n 
0.052
69 
0.78
11 0.1987 
0.126
5 
0.17
51 
0.16
33 0.2639 
0.907
4 
0.404
1 
Std. 
Error 
0.021
51 
0.31
89 0.0811 
0.051
64 
0.07
149 
0.06
667 0.1078 
0.523
9 
0.233
3 
Group 
II 
HEA
RT 
(gms
) 
 
LIV
ER 
(gms
) 
KIDN
EYS 
(gms) 
SPLE
EN 
(gms) 
BRA
IN   
(gms
) 
LUN
G    
(gms
) 
STOM
ACH               
(gms) 
TES
TES 
(gms) 
UTE
RUS 
& 
OVA
RY 
(gms) 
Mean 
0.723
3 
6.54
3 1.293 
0.533
3 1.6 1.75 1.417 3.033 1.2 
Std. 
Deviatio
n 
0.123
1 
1.09
4 0.1593 
0.150
6 
0.08
944 
0.27
39 0.2483 
0.929
2 0.1 
Std. 
Error 
0.050
24 
0.44
65 
0.0650
5 
0.061
46 
0.03
651 
0.11
18 0.1014 
0.536
4 
0.057
74 
Group 
III 
HEA
RT 
(gms
) 
 
LIV
ER 
(gms
) 
KIDN
EYS 
(gms) 
SPLE
EN 
(gms) 
BRA
IN   
(gms
) 
LUN
G    
(gms
) 
STOM
ACH               
(gms) 
TES
TES 
(gms) 
UTE
RUS 
& 
OVA
RY 
(gms) 
Mean 0.555 
5.29
7 1.47 
0.766
7 
1.58
3 
1.61
7 1.333 4 1.467 
Std. 
Deviatio
n 
0.124
2 
1.01
2 0.2161 0.216 
0.19
41 
0.18
35 0.4274 
0.264
6 
0.057
74 
Std. 
Error 
0.050
71 
0.41
33 
0.0882
4 
0.088
19 
0.07
923 
0.07
491 0.1745 
0.152
8 
0.033
33 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females) for Heart, 
Liver, Kidney, Brain, Spleen, Lung, Stomach.   Values are mean ± S.D (n = 3 per 
group per sex ) for testes , ovary and uterus for Control and treatment groups were 
compared statistically using one way ANOVA followed by Dunnett’s test. 
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HISTOPATHOLOGY REPORT 
BRAIN  
Arrangement of the neurons appears intact with no sings of degeneration or apoptotic 
changes were observed in sample belongs to group I,II and III. 
HEART  
Myocardial fiber mass appears denser with no signs of degeneration or fibrosis were 
observed in samples belongs to group I, II and III. 
LUNG  
Light microscopic examination of lung revealed normal alveoli and alveolar sac with 
no signs of infiltration in both control and treated rats. 
STOMACH   
The continuity of mucosa was normal with no evidence of ulceration. Lumina of 
blood vessels appears normal. Appearance of glandular lumen was normal in sample 
belongs to group I, II and III. 
LIVER  
Appearance of portal triad was normal with no signs of inflammatory cell infiltration. 
Liver parenchyma appears normal with no evidence of necrosis were observed in 
sample belongs to group I, II and III. 
KIDNEY  
Appearance of proximal and distal convolutes tubules was normal with no evidence of 
atrophy. Junction between cortex and medulla appears distant in sample belongs to 
group I,II and III. 
SPLEEN 
Erythropoietic cells (EP) are scattered throughout the red pulp of both the samples. 
No abnormalities found in lymph nodes of sample belongs to group I, II and III. 
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TESTES 
Normal sertoli cell aligned properly on the basement membrane with oval dome 
shaped nucleus shows the normal morphology of the seminiferous tubule were 
observed in sample belongs to group I,II and III. 
UTERUS 
Appearance of endometrium, myometrium and uterine glands was normal. 
Arrangement of stratum basale, functionale and surface epithelium seems normal in 
samples belongs to group I,II and III. 
OVARY 
Histopathological analysis of ovary showing normal corpus luteum (CL) and 
Primordial follicles with few mature ovarian follicles with no signs of abnormality. 
Appearance of antral follicle, primary oocyte and secondary follicles are normal in 
sample belong grouI,II and III. 
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Histopathology of Brain (Male Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
     
GROUP I             GROUP II                    GROUP III 
High Power Magnification 40X 
     
GROUP I       GROUP II            GROUP III 
Histopathology of Heart (Male Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
     
GROUP I     GROUP II                GROUP III   
High Power Magnification 40X 
     
     GROUP I                   GROUP II                         GROUP III 
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Histopathology of Kidney (Male Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
     
GROUP I            GROUP II    GROUP III 
High Power Magnification 40X 
      
  GROUP I    GROUP II        GROUP III 
Histopathology of Liver (Male Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
     
GROUP I   GROUP II       GROUP III 
High Power Magnification 40X 
     
GROUP I     GROUP II       GROUP III 
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Histopathology of Lung (Male Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
      
GROUP I          GROUP II    GROUP III 
High Power Magnification 40X 
      
GROUP I          GROUP II    GROUP III 
Histopathology of Spleen (Male Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
     
      GROUP I             GROUP II                GROUP III 
High Power Magnification 40X 
    
GROUP I      GROUP II                 GROUP III 
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Histopathology of Stomach (Male Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
      
GROUP I    GROUP II         GROUP III 
High Power Magnification 40X 
     
GROUP I  GROUP II   GROUP III 
Histopathology of Testes (Male Rat) in Sub-acute toxicity Study 
 Low Power Magnification 10X 
     
GROUP I    GROUP II  GROUP III 
High Power Magnification 40X 
      
GROUP I   GROUP II   GROUP III 
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Histopathology of Brain (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
     
GROUP I         GROUP II  GROUP III 
High Power Magnification 40X 
     
GROUP I     GROUP II     GROUP III 
Histopathology of Heart (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
     
GROUP I     GROUP II      GROUP III 
High Power Magnification 40X 
     I 
     GROUP I  GROUP II    GROUP III 
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Histopathology of Kidney (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
      
GROUP I         GROUP II    GROUP III 
High Power Magnification 40X 
      
GROUP I          GROUP II    GROUP III 
Histopathology of Liver (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
      
GROUP I          GROUP II    GROUP III 
High Power Magnification 40X 
     
GROUP I          GROUP II    GROUP III 
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Histopathology of Lung (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
     
GROUP I          GROUP II    GROUP III 
High Power Magnification 40X 
     
GROUP I          GROUP II    GROUP III 
Histopathology of Spleen (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
     
GROUP I          GROUP II    GROUP III 
High Power Magnification 40X 
     
GROUP I          GROUP II    GROUP III 
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Histopathology of Stomach (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
     
GROUP I     GROUP II       GROUP III 
High Power Magnification 40X 
     
GROUP I      GROUP II                      GROUP III 
Histopathology of Uterus (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
     
GROUP I         GROUP II    GROUP III 
High Power Magnification 40X 
     
        GROUP I                 GROUP II    GROUP III 
 
 
125 
 
Histopathology of Ovary (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
 
     
GROUP I          GROUP II        GROUP III 
High Power Magnification 40X 
 
       
GROUP I          GROUP II          GROUP III
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Pharmacological Evaluation of styptic activity of Naaval nei on Aspirin induced bleeding 
time prolongation in rats. 
Name: Dr.S.Jayapriya 
IAEC: SU/CLATR/IEAC/VII/049/2016 
Animals 
Healthy adult Wistar albino female rats weighing between 220-240 g were 
used for the study.  The animals were housed in poly propylene cages and were kept 
in well ventilated with 100% fresh air by air handling unit. A 12 light / dark cycle 
were maintained .Room temperature was maintained between 22 + 2
o 
C
 
and relative 
humidity 50–65%. They were provided with food (Sai feeds, Bangalore, India) and 
water ad libitum. All the animals were acclimatized to the laboratory for 7 days prior 
to the start of the study. The experimental protocol was approved by The Institutional 
Animal Ethics Committee of Sathyabama University, Chennai, Tamil Nadu, India. 
IAEC: SU/CLATR/IEAC/VII/049/2016 
Experimental Methodology 
The animals were grouped into four groups of 6 animals each. Group I (Control 
group) -received normal saline 5ml/kg, Group II – Aspirin control received 5mg/kg of aspirin, 
p.o. for 35 days. Group III - Received Aspirin (5mg/kg) for 21 days and then treated with 
200mg/kg Naaval nei, p.o weight equivalent to 0.05ml, one hour prior to Aspirin 
administration from day 22 to 35. Group III - Received Aspirin (5mg/kg) for 21 days and then 
treated with 400mg/kg Naaval nei ,p.o weight equivalent to 0.1ml, one hour prior to Aspirin 
administration from day 22 to 35. 
Bleeding time prolongation in rats 
Oral administration of Aspirin (5mg/kg) for 21 days will cause significant 
change in the mean bleeding and clotting times. 
Determination of Bleeding Time 
At the end of 35
th
 day bleeding time was evaluated. The tail of the rat was 
warmed for 1min in water at 40°C and then dried. A small cut was made in tail tip 
with a scalpel. Bleeding time start and was noted when the first drop touched the 
circular filter paper and checked at 15 sec intervals until bleeding stops. 
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Determination of Clotting Time 
Clotting time was determined by capillary tube method.  Capillary tube was 
filled with rat blood collected through retro orbital sinus puncture. Tube was broken 
in to small piece for every 15 sec. As soon as threads of fibrin were noticed, the 
stopwatch was stopped and the time recorded as the clotting time for that particular 
rat. 
Prothrombin time (PT) 
0.1 ml of plasma was mixed with 0.2 ml of PT reagent (Calcium 
thromboplastin) and then the reaction mixture was incubated at 37
o
C, and was 
absorbed until formation of the fibrin clot.  
Effect of Naaval nei on Aspirin induced bleeding time, Clotting time and Prothrombin 
time prolongation in rats. 
Group I 
Bleeding Time 
in Sec 
Clotting Time in 
Sec 
Prothrombin time in 
Sec 
Mean 125 102.5 10 
Std. Deviation 15.49 17.54 0.8944 
Std. Error 6.325 7.159 0.3651 
Group II 
Bleeding Time 
in Sec 
Clotting Time in 
Sec 
Prothrombin time in 
Sec 
Mean 417.5 325 14.83 
Std. Deviation 22.08 26.27 1.941 
Std. Error 9.014 10.72 0.7923 
Group III 
Bleeding Time 
in Sec 
Clotting Time in 
Sec 
Prothrombin time in 
Sec 
Mean 335 267.5 13.33 
Std. Deviation 18.17 22.08 1.211 
Std. Error 7.416 9.014 0.4944 
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Group IV 
Bleeding Time 
in Sec 
Clotting Time in 
Sec 
Prothrombin time in 
Sec 
Mean 277.5 262.5 13 
Std. Deviation 22.75 36.43 1.095 
Std. Error 9.287 14.87 0.4472 
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 Sample Name/ID – SCRI-Novel Nei-2016-17 
Stationary Phase - Silica Gel 60 F254  
Mobile Phase - Tolune : Ethyl Acetate : Formic Acid (5:1.5:0.5 v/ v/v) 
 
  
 
 
 
  = 254 nm  
 
 
  = 366 nm  
 
 White light  
 
Color Rf  value(s) Color Rf  value(s) Color Rf value(s) 
Dark 0.15 Blue 0.06 Brown 0.04 
Dark 0.24 Blue 0.11 Pink 0.24 
Dark 0.38 Green 0.15 Light Pink 0.62 
  Dark 0.24   
  Light Blue 0.35   
  Blue 0.81   
      
      
      
 
HPTLC Chromatogram @ 254 nm:  
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Peak Table @ 254 nm:  
  
3D Chromatogram @ 254 nm: 
 
HPTLC Chromatogram @ 366 nm:                           
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Peak Table @ 366 nm:   
 
3D Chromatogram @ 366 nm: 
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HPTLC Chromatogram @ 554 nm: 
 
Peak Table @ 554 nm: 
 
3D Chromatogram @ 554 nm: 
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BIO-CHEMICAL ANALYSIS OF TRIAL MEDICINE 
 
Preparation of Sodium Carbonate extract: 
 
2 gm of the sample drug is mixed 5 gm of Sodium carbonate and taken in a 
100 ml beaker and 20 ml of distilled water is added. The solution is boiled for 10 
minutes, cooled and then filtered. The filtrate is called sodium carbonate extract. 
 
S.No EXPERIMENT OBSERVATION INFERENCE 
I                                    TEST FOR ACID RADICALS 
1a Test for Sulphate 
2 ml of the above prepared 
extract is taken in a test tube. 
To this add 2ml of 4% 
Ammonium oxalate solution. 
Absence of 
White Precipitate 
Absent 
b 2ml of extract is added with 
2ml of dilute hydrochloric acid 
until the effervescence ceases 
off. Then 2ml barium chloride 
solution is added. 
Absence of 
White Precipitate 
Absent 
2 Test for Chloride: 
2ml of extract is added with 
dilute nitric acid till the 
effervescence ceases. Then 2ml 
of silver nitrate solution is 
added. 
Absence of  
white precipitate 
 
Absent 
3 Test for Phosphate 
2ml of the extract is treated 
with 2 ml of Ammonium 
molybdate solution and 2ml of 
concentrated nitric acid. 
 
Yellow precipitate 
obtained 
Absent 
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4 Test for Carbonate: 
2ml of the extract is treated 
with 2ml of magnesium 
sulphate solution. 
 
Absence of white 
precipitate 
Absent 
5 Test for Sulphide: 
1 gm of the substance is treated 
with 2ml of concentrated 
Hydrochloric acid 
Absence of Rotten 
egg smelling 
Absent 
6 Test for Nitrate: 
1gm of the substance is heated 
with copper turnings and 
concentrated sulphuric acid 
and viewed the test tube 
vertically down. 
Absence of reddish 
brown gas. 
Absent 
 
7a Test for Fluoride and oxalate 
2ml of the extract is added with 
2ml of dilute acetic acid and 
2ml of calcium chloride 
solution and heated. 
Absence of 
White precipitate 
Absent 
b 5 drops of clear solution is 
added with 2ml of dilute 
sulphuric acid and slightly 
warmed to this, 1 ml of dilute 
potassium permanganate 
solution is added. 
 
Absence of KMNO4 
solution 
Discolourisation 
obtained 
Absent 
8 Test for Nitrite 
3 drops of the extract is placed 
on a filter paper. On that, 2 
drops a Acetic Acid and 2 
drops of Benzidine solution is 
placed. 
Absence of 
yellowish red colour 
Absent 
9 Test for Borate Absence of Green Absent 
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2 pinches of the substance is 
made into paste by using 
Sulphuric acid and Alcohol 
(95%) and introduced into the 
blue flame. 
tinged flame 
II                                     TEST FOR BASIC RADICALS 
10 Test for lead 
2 ml of the extract is added 
with 2 ml of Potassium iodide 
solution. 
Absence of Yellow 
precipitate 
Absent 
11a Test for Copper 
One pinch of substance is 
made into paste with 
concentrated Hydrochloric acid 
in a watch glass and introduced 
into the non luminous part of 
the flame. 
Absence of Bluish 
green coloured 
flame. 
Absent 
b 2ml of the extract is added with 
excess of Ammonia solution 
Absence of deep 
blue 
Absent 
12 Test for Aluminium 
To the 2 ml of extract. Sodium 
Hydroxide solution is added in 
drops to excess. 
Absence of White 
Precipitate. 
Absent 
13a Test for Iron 
To the 2 ml of extract, 2 ml of 
Ammonium Thiocyanate 
Solution is added. 
 Blood red colour Present 
b To the 2 ml of extract, 2 ml of 
Ammonium Thiocyanate 
solution and 2 ml of 
concentrated HNO3 is added. 
Blood red colour 
obtained 
Present 
14 Test for Zinc 
To the 2 ml of extract Sodium 
Absence of White 
precipitate. 
Absent 
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Hydroxide solution is added in 
drops to excess. 
15 Test for Calcium 
2 ml of the extract is added 
with 2 ml of 4% Ammonium 
Oxalate solution. 
White precipitate 
Obtained 
Present 
16 Test for Magnesium 
2ml of extract, Sodium 
Hydroxide solution is added in 
drops to excess. 
Absence of White 
precipitate. 
Absent 
17 Test for Ammonium 
2 ml of extract few ml of 
Nessler’s Reagent and excess 
of Sodium Hydroxide solution 
are added. 
Absence of 
Reddish brown 
precipitate 
Absent 
18 Test for Potassium 
A pinch of substance is treated 
with 2 ml of Sodium Nitrite 
solution and then treated with 2 
ml of Cobal Nitrate in 30% 
glacial Acetic acid. 
Absence of Yellow 
precipitate 
 
Absent 
19 Test for Sodium 
2 pinches of the substance is 
made into paste by using 
Hydrochloric acid and 
introduced into the blue flame. 
 
Absence of Yellow 
colour flame 
Absent 
20 Test for Mercury 
2 ml of the extract is treated 
with 2 ml of Sodium 
Hydroxide solution. 
Absence of yellow 
precipitate 
Absent 
21 Test for Arsenic 
2 ml of extract is treated with 2 
ml of silver Nitrate solution 
Absence of 
Yellow precipitate 
Absent 
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22 Test for Starch 
2ml of extract is treated with 
weak iodine solution. 
Absence of 
Blue colour 
Absent 
23 Test of reducing Sugar 
5ml of Benedicts qualitative 
solution is taken in a test tube 
and allowed to boil for 2 
minutes and added 10 drops of 
the extract and again boiled for 
2 minutes. The colour changes 
are noted. 
Green colour 
obtained 
Present 
24 Test of the alkaliods 
2ml of the extract is treated 
with 2ml of potassium lodide 
solution. 
 
 
 
Absence of 
Red colour 
Absent 
25 Test of the proteins 
2ml of the extract is treated 
with 2ml of 5% NaOH ,mix 
well and add 2 drops of copper 
sulphate solution. 
Absence of 
Violet colour 
Absent 
 
RESULTS: 
 
The given sample ( Naaval Nei ) contains  
 
 Iron 
 
Calcium 
 
Reducing sugar. 
 
 
139 
 
 
 
 
 
140 
 
 
 
 
 
 
 
141 
 
BIO – STATISTICS 
CLINICAL PROGNOSIS 
Treatment for Pitha Perumbadu: 
The most popular non parametric statistical tool, namely, McNemar Test 
analysis has been employed to analyses the effectiveness with the help of a 
hypothesis. 
S. No Signs&Symptoms Before Treatment After Treatment 
n% n% 
1. Excessive Menstruation 20(100) 1(5)** 
2. Prolonged Menstruation           20(100) 0(0)** 
3. Presence Of Blood Clots 20(100) 0(0)** 
4. Lower Abdominal Pain 15(75) 1(5)** 
5. Low Back Ache 10(50) 1(5)** 
6. Tiredness 20(100) 0(0)** 
7. Giddiness 13(65) 1(5)** 
8. Head Ache 3(15) 0(0)** 
McNemat test, C.I: 95%,  *P<0.05; **P<0.01 
Software: spss17 version 
Number of cases: 20 
Inference:  
Since the p value is significant in all signs and symptoms. So there is 
significant reducing of signs & symptoms among the patients for the treatment of 
Pitha Perumbadu (Menorrhagia). Hence it is concluded that the treatment was 
effective and significant. 
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NUMBER OF PADS USED BY THE PATIENTS 
BEFORE AND AFTER TREATMENT 
Effect of Naaval Nei on number of pads used by the patients 
S. no Number of Pads for a cycle 
Before Treatment After Treatment 
1. 16 10 
2. 22 13 
3. 14 10 
4. 10 7 
5. 15 10 
6. 13 8 
7. 18 11 
8. 14 10 
9. 26 21 
10. 11 8 
11. 22 13 
12. 13 9 
13. 15 10 
14. 15 11 
15. 16 11 
16. 20 12 
17. 12 8 
18. 14 10 
19. 13 9 
20. 15 10 
Software: spss17 version 
Variables: Number of Pads– before treatment, after treatment 
Number of cases: 20 
Test: Paired t test 
 
 
143 
 
Confidence Interval: 95% 
Correlation coefficient (r): 0.918 
Before and after treatment Mean difference ±SEM: 5.15±0.40.  
P Value (2 tailed): p<0.01. 
Inference: Since the P value is highly significant (<0.01), The hypothesis is not 
accepted.  So the treatment was significantly reducing the number of pads used by the 
patients for the treatment of Pitha Perumbadu. 
HAEMOGLOBIN  LEVEL: 
Effect of Naaval Nei on Hb level (gm/dl)in pitha perumbadu cases 
S. no Haemoglobin level in gms/100ml of blood 
Before Treatment After Treatment 
1. 8.0 9.1 
2. 6.4 8.3 
3. 8.1 9.5 
4. 9.0 10.2 
5. 9.6 10.5 
6. 10.0 10.8 
7. 9.2 10.5 
8. 9.8 10.5 
9. 7.0 7.9 
10. 10.8 11.4 
11. 9.4 10.6 
12. 9.8 10.5 
13. 9.4 10.2 
14. 9.2 10.2 
15. 10.6 11.2 
16. 8.0 9.4 
17. 9.0 10.2 
18. 9.7 10.6 
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19. 8.3 9.1 
20. 8.5 10.3 
Software: spss17 version 
Variables: Hb level (gm/dl)– before treatment, after treatment 
Number of cases: 20 
Test: Paired t test 
Confidence Interval: 95% 
Correlation coefficient (r): 0.955 
Before and after treatment mean difference: 1.06 ± 0.08. 
P Value (2 tailed): p<0.001. 
Inference:  
Since the P value is highly significant (<0.001), The hypothesis is not 
accepted.  So the treatment was significantly improving the Hb level among the 
patients for the treatment of Pitha Perumbadu. 
BLEEDING TIME: 
Effect of Naaval Nei on bleeding time in pitha perumbadu cases 
S. no Bleeding Time(min) 
Before Treatment After Treatment 
1. 2.90 2.30 
2. 2.17 1.36 
3. 3.17 2.90 
4. 2.20 2.17 
5. 3.45 2.73 
6. 2.60 1.17 
7. 3.45 2.17 
8. 2.17 1.17 
9. 3.13 2.97 
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10. 2.70 2.67 
11. 1.80 1.30 
12. 2.67 1.13 
13. 3.60 2.17 
14. 2.17 1.90 
15. 2.90 2.10 
16. 2.17 1.77 
17. 3.15 2.07 
18. 2.40 2.03 
19. 2.90 1.98 
20. 2.92 2.03 
 
Software: spss17 version 
Variables:bleeding time(min)– before treatment, after treatment 
Number of cases: 20 
Test: Paired t test 
Confidence Interval: 95% 
Correlation coefficient (r): 0.617 
Before and after treatment mean difference ± SEM: 0.73 ± 0.10.  
P Value (2 tailed): p<0.001. 
Inference:  
Since the P value is significant (<0.001), The hypothesis is not accepted.  So 
the treatment was significantly reducing the bleeding time among the patients for the 
treatment of Pitha Perumbadu. 
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CLOTTNG TIME: 
Effect of Naaval Nei on clotting time in pitha perumbadu cases 
S. no Clotting Time(min) 
Before Treatment After Treatment 
1. 4.80 5.20 
2. 4.80 4.23 
3. 4.91 4.28 
4. 6.70 5.67 
5. 6.03 6.68 
6. 4.87 5.42 
7. 5.40 4.30 
8. 5.73 5.17 
9. 6.57 6.03 
10. 5.63 4.85 
11. 5.37 5.53 
12. 4.60 3.83 
13. 5.73 5.17 
14. 3.92 3.17 
15. 3.40 3.33 
16. 5.17 4.85 
17. 5.80 5.27 
18. 5.67 4.65 
19. 6.40 5.25 
20. 6.17 5.65 
 
Software: spss17 version 
Variables: clotting time(min)– before treatment, after treatment 
Number of cases: 20 
Test: Paired t test 
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Confidence Interval: 95% 
Correlation coefficient (r): 0.808 
Before and after treatment mean difference ± SEM: 0.46 ± 0.12.  
P Value (2 tailed): p<0.01. 
Inference:  
Since the P value is significant (<0.01), The hypothesis is not accepted.  So 
the treatment was significantly reducing the clotting time among the patients for the 
treatment of Pitha Perumbadu. 
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CONSENT FORM 
GOVERNMENT SIDDHA MEDICAL COLLEGE 
ARIGNAR ANNA GOVERNMENT HOSPITAL OF INDIAN MEDICINE 
CHENNAI – 600 106 
CLINICAL STUDY ON “NAAVAL NEI” IN THE TREATMENT OF 
“PITHA PERUMBADU” (MENORRHAGIA). 
                                    
“I have read the foregoing information, or it has been read to me. I have 
had the opportunity to ask questions about it and any questions I have asked have 
been answered to my satisfaction. 
            I   consent voluntarily to participate in this study and understand that I have 
the   right to withdraw from the study at any time without in any way it affecting my 
further medical care”. 
"I have received a copy of the information sheet/consent form". 
Date:    
Station:                                                                                  
Signature of participant:  
 
 
Signature of the Guide:    Signature of the Investigator:  
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அ஧சிணர் சித்஡ ஥ருத்து஬க் கல்லூரி,சசன்னண 106. 
அநிஞர் அண்஠ா ஥ருத்து஬஥னண, சசன்னண 106 
தித்஡ சதரும்தாடு ந஢ாய்க்காண  சித்஡ ஥ருந்஡ின் ( ஢ா஬ல் ச஢ய் ) தரிகரிப்பு 
஡ிநனணக் கண்டநியும் ஥ருத்து஬ ஆய்஬ிற்காண ந஢ா஦ாபி஦ின்                 
ஒப்பு஡ல் தடி஬ம். 
                    ஆய்஬ாப஧ால் சான்நபிக்கப்தட்டது: 
   ஢ான் இந்஡ ஆய்ன஬ குநித்஡ அனணத்து ஬ித஧ங்கனபயும் ந஢ா஦ாபிக்குப் 
புரியும் ஬னக஦ில் எடுத்துன஧த்ந஡ன். 
ந஡஡ி:                                னகச஦ாப்தம்: 
இடம்:                                சத஦ர்: 
                     ந஢ா஦ாபி஦ின் ஒப்பு஡ல் 
என்ணிடம் இந்஡ ஥ருத்து஬ ஆய்஬ின் கா஧஠த்ன஡யும், ஥ருந்஡ின் 
஡ன்ன஥ன஦யும், ஥ருத்து஬ ஬஫ிமுனநன஦யும் ஥ற்றும் ச஡ாடர்ந்து எணது 
உடல் இ஦க்கத்ன஡ கண்கா஠ிக்கவும், அ஡னண தாதுகாக்கவும் த஦ன்தடும் 
஥ருத்து஬ ஆய்வுக்கூட தரிநசா஡னணகள் தற்நி ஡ிருப்஡ி அபிக்கும் ஬னக஦ில் 
ஆய்வு ஥ருத்து஬஧ால் ஬ிபக்கிக் கூநப்தட்டது. 
஢ான் இந்஡ ஥ருத்து஬ ஆய்஬ின் நதாது , கா஧஠ம் எதுவும் கூநா஥ல், 
எப்நதாது ந஬ண்டு஥ாணாலும் இந்஡ ஆய்஬ினிருந்து என்னண ஬ிடு஬ித்துக் 
சகாள்ல௃ம் உரின஥ன஦ ச஡ரிந்஡ிருக்கிநநன். ஢ான் என்னுனட஦ சு஡ந்஡ி஧஥ாக 
ந஡ர்வு சசய்யும் உரின஥ன஦க் சகாண்டு தித்஡ சதரும்தாடு ந஢ாய்க்காண 
஢ா஬ல் ச஢ய் தரிகரிப்புத் ஡ிநனணக் கண்டநியும் ஥ருத்து஬ ஆய்஬ிற்கு 
என்னண உட்தடுத்஡ ஒப்பு஡ல் அபிக்கிநநன்.                     
ந஡஡ி:                                        னகச஦ாப்தம்: 
இடம்:                                        சத஦ர்: 
உநவுமுனந:                                சாட்சிக்கா஧ர் னகச஦ாப்தம்: 
ந஡஡ி:                                        சத஦ர்: 
இடம்:                                 
துனநத்஡னன஬ர் னகச஦ாப்தம்                 ஆய்஬ாபர் னகச஦ாப்தம் 
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CASE SHEET PROFORMA 
GOVT.SIDDHA MEDICAL COLLEGE & HOSPITAL, CHENNAI-106 
POST GRADUATE DEPARTMENT BRANCH –I MARUTHUVAM 
CASE SHEET PROFORMA FOR PERUMBADU 
 
OP No / IP No :               Nationality : Indian
            
 
Ward No  :                 Religion :                
 
Bed No                       :                                                D.O.A            :       
                                                                                     
Name   :                 D.O.D             :  
 
Age   :                                                                                      
        
 
Sex   :  Female                                              Diagnosis         :      
 
Occupation               :                                                                                         
 
Income                        :                                                                                                                                                                    
 
Permanent Address  :         
 
 
Temporary Address   : Govt.Siddha Medical college, 
                                        Chennai-600106 
1. Complaints and duration : 
 
 
 
2. History of present illness : 
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3. History of past illness :           
 
   
4. Personal history  :   
 
 
5. Occupational history  :            
 
 
6. Menstrual history  : 
 
a) Regularity of cycle  :   Regular / Irregular 
 
 
b) Length of cycle (days)      :    
 
 
c) Duration of flow (days)    :    
 
d) Level of flow                     :    Low/ Moderate /Heavy 
 
e) Abdominal pain   :    Nil/ Mild/ Moderate/ Severe 
 
f) LMP                                    : 
 
g) Number of pads used 
    per cycle   : 
 
7. Personal Habits  :   Veg/nonveg/smoker/Alcocoholic/Tobacco chewer 
 
 
8. Family History  :                                                                                                                                
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9.Obstetric History               :                                                                                                                                                                                                                                           
   
GENERAL EXAMINATION  
Patient consciousness  :  
Body Built    : 
Nourishment    : 
Anaemia    : 
Jaundice    : 
Cyanosis    : 
Clubbing    : 
JVP     : 
Tracheal deviation   : 
Pedal oedema   : 
Lymph adenopathy   : 
 
VITAL SIGNS 
Heart rate    : 
Pulse rate    : 
Respiratory rate   : 
Blood Pressure   : 
Body Temperature   : 
Weight    : 
Height     : 
 
SIDDHA ASPECT  
 
NILAM 
Kurinchi  : 
Mullai   : 
Marutham  : 
Neithal  : 
Palai                         : 
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PARUVAKAALAM 
Kaar kalam  : 
Koor kalam  : 
Munpani kalam : 
Pinpani kalam : 
Elavenil kalam : 
Muduvenil  : 
 
YAAKKAI (Udal) 
Vaatham  : 
Pitham  :            
Kabam  :  
Kalappu  : 
 
GUNAM 
Satthuvam  : 
Rajotham  : 
Thamasam  : 
 
PORI/PULANGAL (SENSORY ORGANS) 
Mei (Sensation)   : 
Vaai ( Taste)    : 
Kan( Vision)     : 
Mooku ( Smell)    : 
Sevi ( Hearing)   : 
 
KANMENTHRIYAM/KANNMAVIDAYAM [MOTOR ORGANS] 
Kai ( Dhaanam)   :  
Kaal ( Kamanam)   : 
Vaai ( Vasanam)   :  
Eruvaai( Visarkkam)  :  
Karuvaai (Aanantham)  : 
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UYIR THATHUKKAL 
VATHAM 
 Praanan   : 
 Abanan   : 
 Viyanan   : 
 Udanan   : 
 Samanan   : 
 Nagan    : 
 Koorman   : 
 Kirukaran   : 
Devathathan   : 
Thananjeyan   : 
PITHAM 
Anar pitham   : 
Ranjaga pitham  : 
Saathaga pitham  : 
Pirasaga pitham  : 
Alosaga pitham  : 
   KAPAM 
Avalambagam  :  
Kilethagam   :  
Pothagam   : 
Tharpagam   : 
Santhigam   : 
 
UDALTHAATHUKKAL 
Saaram   :  
Senner   :  
Oon    : 
Kozhuppu   : 
Enbu    : 
Moolai   : 
Suronitham   :  
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ENVAGAI THERVUGAL 
1. Naa    : 
2. Niram   : 
3. Mozhi   : 
4. Vizhi   :  
5. Sparisam   : 
6. Malam   : 
7. Naadi   : 
8. Moothiram 
a) Neer Kuri  : 
                        Niram   : 
  Manam  : 
  Edai   : 
  Nurai   :  
  Enjal   : 
 b) Nei Kuri  : 
 
MODERN ASPECT 
Sytemic Examination 
Inspection    : 
 
Palpation    : 
 
Percussion    : 
 
Auscultation    : 
 
Others Systems 
Cardio Vascular System   : 
Respiratory system   : 
Central nervous system  : 
Genito urinary system  : 
Endocrine system    :
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CLINICAL SIGN AND SYMPTOMS OF PERUMBADU 
Symptoms 
Before 
Treatment 
After Treatment 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
I 
7 days 
II  
9 days 
III 
12 days 
      IV               
30 days 
V 
48days 
 
1.Vaginal Bleeding  
             No of pads                    
 
      
2. Vaginal Bleeding 
No of days 
 
      
3.Passing blood clots       
4. Abdomen pain 
 
      
5. Loss of appetite       
6. Anaemia       
7.Myalgia       
8.Tiredness       
9. Head ache       
10. Giddiness        
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INVESTIGATIONS 
1.BLOOD INVESTIGATIONS : 
 
BLOOD INVESTIGATIONS 
 
 
BEFORE 
TREATMENT 
 
 
 
AFTER TREATMENT 
 
Hb (gms/dl) 
  
 
T.RBC(millions cells/cu.mm) 
  
 
ESR (mm) 
½ hr   
1 hr   
T.WBC (cells/cu.mm)   
 
Differential 
Count (%) 
Polymorphs   
Lymphocytes   
Eosinophils   
  
 
 
BLOOD INVESTIGATIONS 
 
BEFORE TREATMENT 
 
AFTER TREATMENT 
Bleeding time    
Clotting time   
Blood glucose (mg/dl) (R)   
Blood urea    
Serum cholesterol   
 
2.URINE INVESTIGATION  
URINE INVESTIGATION BEFORE TREATMENT AFTER TREATMENT 
Albumin   
Sugar   
Desposits   
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3. SONOGRAPHY 
          USG Abdomen and Pelvis 
 
  4.SMEAR STUDY 
     PAP smear 
     
 CASE SUMMARY 
 
 
 
 DIAGNOSIS                      :  PITHA PERUMBADU 
 
 TRIAL DRUG                           :  NAAVAL NEI 
  
  Dose                                 :  5 gm; Thrice a day after food . 
 
  Duration of Treatment     :  For 1 mandalam (48 days) 
 
REPORTS : 
 
DATE 
 
WEEKLY REPORTS 
 
MEDICINE 
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ADVICE 
 DO’S 
 Take balanced and healthy food. 
 Take rest in comfort bed 
  Use sanitary pads. 
 DON’TS    
 Don’t travel  
Don’t do heavy work 
 
PROGNOSIS AT THE END OF THE TREATMENT : 
Reducing in clinical symptoms and by comparing the following parameters before 
and after treatment. 
1.Number of pads used for a cycle 
2.Haemoglobin level. 
 
 
 
Medical Officer Signature:                                                                      HOD 
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